Jamie Bell

1174 POSTS 0 COMMENTS

Boston Scientific obtains CE mark for image-guided programming software in DBS

Boston Scientific Corporation has obtained a CE mark for the Vercise neural navigator 5 software with STIMVIEW XT technology, which—when used as part of...

TCAR and endarterectomy both ‘reasonable’ but stenting linked to worse outcomes...

A study examining outcomes between different carotid revascularisation procedures has concluded that transcarotid artery revascularisation (TCAR) and carotid endarterectomy (CEA) both represent a “reasonable...

Patient selection may explain ‘counterintuitive’ relationship between carotid stenting volume and...

High stroke and death rates relating to carotid stenting in the Pacific Northwest of the USA may be driven by the selection of high-risk...

Penumbra announces European launch of BMX81 and BMX96 neuro access offerings

Penumbra has announced the CE mark and European launch of BMX81 and BMX96—devices designed for the neurovascular management of ischaemic and haemorrhagic stroke. A...

CEA versus TCAR: surgeons should be familiar with both procedures and...

When it comes to the ongoing debate of carotid endarterectomy (CEA) versus transcarotid artery revascularisation (TCAR) in the treatment of carotid artery stenosis, operators...

ESO taskforce provides forecast for European launch of stroke thrombolysis drugs

The European Stroke Organisation (ESO) Executive Committee’s Thrombolysis Taskforce has provided “important updates” regarding the security of supply for Metalyse (tenecteplase) and Actilyse (alteplase)...

Short-pulse DBS appears more effective than conventional DBS in tremor but...

In a systematic review and meta-analysis of the current literature, deep brain stimulation (DBS) with a short pulse width has been shown to potentially...

New Siemens-WSO partnership to tackle stroke’s “disastrous disease trajectory”

Siemens Healthineers and the World Stroke Organization (WSO) have announced a two-year partnership to develop the acute stroke workforce, and improve treatment and care...

Zeto obtains US FDA 510(k) clearance for next-generation brain monitoring product

Zeto has announced that its innovative, next-generation brain monitoring product, named the ONE, has received 510(k) clearance from the US Food and Drug Administration (FDA). "Zeto...

NeuroNews’ top 10 most popular stories of May 2024

Global conference coverage piqued NeuroNews readers’ interest through the month of May—initially with discussions at the Charing Cross (CX) International Symposium (23–25 April, London,...

Adnan Siddiqui

While he is a neurosurgeon by trade, Adnan Siddiqui (Buffalo, USA) has delved into an increasing number of domains throughout his career—not only through...

Nalu PNS system achieves significant and durable pain reduction in COMFORT...

Nalu Medical has revealed findings from a landmark clinical trial evaluating its Nalu peripheral nerve stimulation (PNS) system, utilising the company’s proprietary micro-implantable pulse...

ESMINT signs memorandum of understanding with German Society of Neuroradiology

In acknowledgement of their shared goals and interests, the European Society of Minimally Invasive Neurological Therapy (ESMINT) and the German Society of Neuroradiology (DGNR) announced...

First-in-human data demonstrate Clotild smart guidewire can safely automate clot characterisation

Earlier today, Sensome announced positive results from its first-in-human CLOT OUT clinical trial evaluating the safety and performance of the company’s Clotild smart guidewire...

Medtronic unveils next-generation Artisse intrasaccular device alongside new data at LINNC...

Medtronic has today announced the European launch of Artisse—a new intrasaccular device designed to treat intracranial aneurysms by conforming to the shape of the...

US researchers pioneer new brain imaging technique through ‘clear window’ in...

In what has been described as the first study of its kind, researchers from the Keck School of Medicine at the University of Southern...

Conformability, softness, simplicity and simulation enable Artisse to ‘personalise’ treatments in...

This advertorial, intended for readers outside the USA only, is sponsored by Medtronic. In light of the official European launch of the Artisse aneurysm embolisation...

Positive HEMERA-1 data pave the way for further neuroprotection trials during...

Following the recent publication in Stroke: Vascular and Interventional Neurology of results from HEMERA-1, a prospective, multicentre trial evaluating the safety of novel neuroprotective...

Thrombolysis appears less effective in tandem-lesion stroke patients presenting directly to...

Intravenous thrombolysis (IVT) prior to a mechanical thrombectomy procedure appears to be less effective in ischaemic stroke patients with carotid-artery tandem lesions, as compared...

Seven-year data provide “compelling evidence” that intracranial stenting does not confer...

Seven-year data from the Chinese CASSISS trial have, in the investigators’ view, provided “compelling evidence” that percutaneous transluminal angioplasty and stenting (PTAS) plus medical...

Mobile app successfully improves stroke medication adherence and risk-factor control

The use of a smartphone-based mobile application may be an effective method for improving medication adherence and risk-factor control among stroke survivors, and appears...

Varied tenecteplase data may provide clarity on the drug’s exact role...

This year’s European Stroke Organisation Conference (ESOC; 15–17 May, Basel, Switzerland) saw a plethora of data on intravenous tenecteplase—from studies spanning Australia, Canada, China,...

Ceretrieve announces successful results in FIH study of stroke aspiration catheter

Ceretrieve has announced the successful results of the company's multicentre, single-arm study, showcasing the capabilities of its “state-of-the-art” aspiration catheter in stroke treatment. The study—conducted across two...

Medtronic names Linnea Burman as new head of Neurovascular business

Medtronic has today announced that Linnea Burman will succeed Dan Volz as its senior vice president (SVP) and president of its Neurovascular business—part of...

Spryte publishes first-in-human study of novel intravascular brain imaging technology

Spryte Medical has announced the publication of a first-in-human study of its neuro optical coherence tomography (nOCT) technology in the peer-reviewed journal Science Translational Medicine, in...

Hippo-Cheetah combination: a whole new animal in aspiration thrombectomy

This advertorial, intended for US readers only, is sponsored by Q’Apel Medical. Hot on the heels of the device’s Food and Drug Administration (FDA) approval...

Stroke transfer protocols: what does the road ahead look like?

A number of somewhat conflicting studies have been published over the past year regarding triage and transport protocols for stroke. In light of the...

AiM partners with Brigham and Women’s Hospital to validate DBS lead...

AiM Medical Robotics has announced a collaboration with Brigham and Women's Hospital (BWH; Boston, USA), and the Surgical Navigation and Robotics (SNR) Lab at Harvard, to validate its cutting-edge robot...

ARISE I recommends multidisciplinary approach to managing brain aneurysms, chronic SDHs...

Three papers published in the journal Stroke have highlighted multidisciplinary care and global, collaborative efforts as “paramount” in the management of intracranial aneurysms, chronic...

Vesalio appoints chief financial officer and announces new company headquarters

vesalio
Vesalio is set to welcome J D McCulloch as its chief financial officer (CFO) for overseeing all financial aspects of the business, and helping...

XCath successfully performs first public telerobotic mechanical thrombectomy demonstration

XCath has announced the successful completion of a “first-of-its-kind” live telerobotic trial for stroke treatment, which took place between Abu Dhabi, United Arab Emirates...

Evidence weak but craniectomy may be superior to medical therapy in...

Despite the study very narrowly failing to meet its prespecified primary endpoint, the SWITCH randomised controlled trial has shown a substantial treatment effect with...

NeuroNews issue 54 – US

Highlights: ARISE I recommendations on the management of intracranial aneurysms, chronic subdural haematomas (cSDHs) and brain arteriovenous malformations (AVMs) First European presentation of PERFORMANCE...

NeuroNews issue 54 – OUS

Highlights: ARISE I recommendations on the management of intracranial aneurysms, chronic subdural haematomas (cSDHs) and brain arteriovenous malformations (AVMs) First European presentation of PERFORMANCE...

MagVenture and Magnus to collaborate on bringing SAINT neuromodulation system to...

MagVenture has announced a partnership with Magnus Medical that is intended to provide its industry-leading MagPro magnetic stimulation system to support an “exciting new chapter”...

Large-core ischaemic stroke patients with severe hypodensity may benefit less from...

While the randomised controlled SELECT2 trial initially found that patients with large-core ischaemic stroke receive a greater benefit from thrombectomy compared to medical management,...

‘Time is brain’ in ICH but early identification of stroke type...

The latest data from the INTERACT trials—a series of studies evaluating intensive blood-pressure (BP) lowering in acute haemorrhagic stroke—point towards the importance of initiating...

Thrombectomy shows long-term benefit in large-infarct stroke patients diagnosed via ‘pragmatic’...

The TENSION trial, conducted across 41 hospitals in Europe and Canada, has unveiled new insights into the long-term efficacy of endovascular mechanical thrombectomy in...

Brainomix announces increased thrombectomy rates at UK centres using its AI...

Brainomix has announced that results from what it claims is the largest prospective study of stroke artificial intelligence (AI) software were presented yesterday at...

‘TACTICS’ intervention shows promise for improving EVT access in Australia

TACTICS, a non-randomised intervention trial that aimed to optimise workflow and implement specialised imaging, has shown promise in improving access to endovascular therapy (EVT)...

Rapid Medical completes successful stroke procedures with “world’s first” robotic thrombectomy...

Rapid Medical has announced what it claims is the first successful robotic thrombectomy, in Medellín, Colombia. Two patients were treated with the robotic Tigertriever—an...

Higher income reduces stroke mortality risk by a third, new study...

New research, presented today at the 10th European Stroke Organisation Conference (ESOC 2024; 15–17 May, Basel, Switzerland), has revealed that high-income individuals have a...

Cerevasc secures US$70 million financing following US FDA approval of STRIDE...

Cerevasc announced recently that it has successfully completed the initial closing of a US$70 million Series B financing, which was jointly led by Bain Capital Life...

Hyperfine to expand into European markets with initial focus on France,...

Hyperfine has announced that it has entered into agreements with three experienced and accomplished distributors to support commercial expansion plans of the Swoop system—the...

Carryover effect exists and has “remarkably high” variability in spinal cord...

An international, multicentre study has confirmed the existence of the carryover or ‘echo’ effect—an interval before patients perceive the return of pain after their...

NeuroNews’ top 10 most popular stories of April 2024

NeuroNews’ top 10 most popular stories of April 2024 include the European launch of a new aspiration catheter for acute ischaemic stroke treatment, a...

RapidAI secures US FDA clearance for perfusion imaging tool within angio...

RapidAI has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its AngioFlow by RapidAI solution. As per a company press...

First European PERFORMANCE II release highlights durability of carotid stenting in...

The recent, first-time European presentation of the PERFORMANCE II trial’s findings—delivered by Ralf Langhoff (Sankt Gertrauden-Krankenhaus, Berlin, Germany) at the 2024 Charing Cross (CX)...

Penumbra launches Midway intermediate catheters and expands European stroke portfolio

Today, Penumbra announced the launch of its Midway 43 and Midway 62 delivery catheters, which are designed to provide ideal tracking and a stable...

New Myriad Spectra system described as “gamechanger” in high-grade glioma brain...

The latest product innovation by Nico Corporation, the Myriad Spectra system, has been described as a "game-changing advancement" by neurosurgeons with early experience using...

Vagus nerve stimulation demonstrates promise as non-medical treatment for narcolepsy

An initial evaluation of vagus nerve stimulation (VNS) in narcolepsy patients has linked this neuromodulation modality to a “significant improvement” in daytime sleepiness, leading...

MindRhythm announces EPISODE-PS-COVID publication revealing Harmony’s reliability in identifying LVO stroke

MindRhythm has announced that results from the pilot phase of its three-phase clinical study, EPISODE, have been published in Academic Emergency Medicine. While pilot...

Study elucidates how patient age and electrode connectivity impact cognitive effects...

A study presented at the recent American Academy of Neurology (AAN) annual meeting (13–18 April, Denver, USA) has gone some way to elucidating how...

Route 92 announces US FDA 510(k) clearance for FreeClimb 54 reperfusion...

Route 92 Medical has today announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the FreeClimb 54 reperfusion system, comprised of...

ESMINT issues ‘call for experts’ to streamline EU medical device certification

The European Society of Minimally Invasive Neurological Therapy (ESMINT) has issued a call for experts in neurointerventions to work with notified bodies over the...

Viz.ai and Nico announce collaboration to improve interventional ICH outcomes

Viz.ai has announced a collaboration with Nico Corporation to improve the lives of patients with intracranial haemorrhages (ICHs), leveraging the former’s artificial intelligence (AI)-powered...

Insightec launches next-generation Exablate Prime neurosurgery platform in Europe

Insightec has announced the CE-mark approval and European launch of Exablate Prime, which the company describes as a “significant enhancement” to its Exablate Neuro...

Early technique switches “should be contemplated” following failed thrombectomy attempts

A retrospective analysis including data from close to 3,000 stroke patients has concluded that early changes in mechanical thrombectomy strategies may be associated with...

Cognito announces OVERTURE II results indicating durable effects of Spectris treatment...

Cognito Therapeutics has announced treatment results from OVERTURE II—an open-label extension (OLE) study of Spectris, the company’s potential disease-modifying therapy for the treatment of...

Growing haemorrhagic stroke burden in USA represents “major challenge” moving forward

The past three decades have seen a “notable rise” in the burden of haemorrhagic stroke across the USA and this, coupled with the increasing...

ENRICH trial results published in full in New England Journal of...

The entirety of the results from the ENRICH trial evaluating the early surgical removal of intracranial haemorrhage (ICH) have been published in the New England...

SpineX closes recruitment for trial evaluating Scone SCS technology in neurogenic...

SpineX has closed recruitment for the CONTINENCE clinical trial of its proprietary Scone device. The study began back in May 2022 and is evaluating...

Synchron launches patient registry for Stentrode brain-computer interface

Synchron has announced the launch of a community-centred brain-computer interface (BCI) registry to bring patients, carers and clinicians together to learn how BCI technology...

Study reinforces ‘widely held but underexplored’ view that ECT is safe...

Researchers have found that electroconvulsive therapy (ECT)—whereby an electric current is passed through the brain of a patient under general anaesthesia to induce a...

XCath highlights endovascular robotics innovation at SLICE Next Frontiers

XCath has announced that it presented at the recent Stroke Live Course (SLICE) Next Frontiers conference (3–4 April, virtual), hosted by Vincent Costalat (University Hospital...

NeuroNews’ top 10 most popular stories of March 2024

Major pieces of industry news from a number of innovators in the neurovascular space populate NeuroNews’ top 10 articles of last month—including NeuroOne, Artiria,...

RapidPulse’s precise cyclic aspiration technology “highly effective and safe” in LVO...

A study recently published online in the journal Interventional Neuroradiology has provided multicentre trial results that demonstrate the promise of using precise cyclic aspiration in the...

AI language model shows “encouraging” potential in locating brain lesions after...

Artificial intelligence (AI) may serve as a future tool for neurologists to help locate the part of the brain in which a stroke occurred,...

Silk Road adds Enroute NPS Plus device to TCAR portfolio

Silk Road Medical has announced the launch of its Enroute transcarotid neuroprotection system Plus (NPS Plus), which the company describes as a key component of...

Debates, case carousel and European first head up CX carotid and...

The programme for the 2024 Charing Cross (CX) symposium (23–25 April, London, UK) will see the topics of acute stroke care, carotid disease and...

Early DAPT, statin therapy and stent patency among predictors of good...

An analysis involving some 300 patients with anterior-circulation acute ischaemic strokes caused by tandem lesions has determined a number of factors that may be...

Dedicated devices support progress towards “next frontier” for stroke thrombectomy

This advertorial, intended for readers outside the USA only, is sponsored by Medtronic. In light of a recent publication detailing the safe and effective use...

New data underscore physician experience levels required to derive benefit from...

Data from a new study that maps out the levels at which adverse postoperative events decrease following transfemoral carotid artery stenting (TfCAS) based on...

Research, training and industry all key to better thrombectomy care in...

This advertorial is sponsored by Medtronic. Late last year, on 24 November, a decade’s work from a passionate group of physicians bore fruit, with the...

Viz.ai and Medtronic to collaborate on improving post-cryptogenic stroke care in...

Viz.ai has announced a strategic collaboration with Medtronic to improve the coordination of cryptogenic stroke patient care between neurology and cardiology teams. For stroke patients...

Michihiro Tanaka

Michihiro Tanaka
Michihiro Tanaka, director of Neurosurgery and Neuroendovascular Surgery at Kameda Medical Center (Chiba, Japan), speaks to NeuroNews to discuss the factors that have shaped...

Transradial achieves non-inferiority but procedural delays may mean femoral access remains...

In stroke patients undergoing a mechanical thrombectomy procedure, access via the radial artery may be non-inferior to access through the femoral artery in terms...

UK study indicates post-stroke depression may be more common and long-lasting...

Researchers have argued that “more needs to be done” for depressed stroke survivors in light of new findings showing that almost 60% of stroke...

NeuroOne initiates limited commercial launch of OneRF ablation system

NeuroOne Medical Technologies has announced that it has initiated a limited commercial launch of its OneRF ablation system, which has US Food and Drug Administration...

Avicenna.AI secures US FDA 510(k) clearance for two AI-powered imaging tools

Avicenna.AI announced today that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its CINA-ASPECTS and CINA-iPE products. CINA-ASPECTS is...

US patent office rejects Axonics’ latest challenge to Medtronic patents

Medtronic has announced that the Patent Trial and Appeal Board (PTAB) of the US Patent and Trademark Office has affirmed the validity of claims...

Meta-analysis deems venous sinus stenting a safe and effective option in...

A meta-analysis published recently in the Journal of the Neurological Sciences has concluded that venous sinus stenting (VSS) appears to be a safe and...

NeuroNews issue 53 – US

Highlights: The “major shift” likely to occur following presentation of three large-scale trials evaluating middle meningeal artery (MMA) embolisation for chronic subdural haematoma (SDH) ...

NeuroNews issue 53 – OUS

Highlights: The "major shift" likely to occur following presentation of three large-scale trials evaluating middle meningeal artery (MMA) embolisation for chronic subdural haematoma (SDH) ...

Arissa reports initial six-month radiographic follow-up from Syntra FIH study

Arissa Medical has announced six-month digital subtraction angiography (DSA) follow-up of the first cohort of patients in its Syntra first-in-human (FIH) study—an early feasibility...

Mainstay announces publication of five-year follow-up data from ReActiv8-B trial

Mainstay Medical has announced the publication of the five-year follow-up from its ReActiv8-B randomised, sham-controlled, double-blinded trial in Neuromodulation: Technology at the Neural Interface. There...

Shining a light on hereditary brain aneurysms

Intracranial aneurysms are a largely underestimated condition, for which global awareness and clinical research are currently lacking—and these sentiments apply even more pertinently when...

Axonics receives CE-mark approval for fourth-generation rechargeable SNM therapy

Axonics has announced that the Axonics R20 rechargeable sacral neuromodulation (SNM) system has received CE-mark approval. Axonics expects to commence sales of the R20 to...

Single-centre analysis suggests improved longer-term outcomes with endarterectomy versus TCAR

A large, single-centre analysis has found that, despite parity between the two procedures in terms of perioperative clinical outcomes, carotid endarterectomy (CEA) was associated...

Nanoflex Robotics installs its first remote-ready robotics system in North America

Switzerland-based startup firm Nanoflex Robotics has announced that it recently installed its first remote-ready robotics system for neurovascular procedures at the Jacobs Institute (Buffalo,...

NeuroNews’ top 10 most popular stories of February 2024

Our list of the most popular stories from last month is dominated by first-time data releases from the International Stroke Conference (ISC; 7–9 February,...

Apollo Hospitals unveils South Asia’s first ZAP-X radiosurgery platform

Apollo Hospitals announced today that one of its centres in New Delhi, India has become the first hospital in South Asia to introduce the...

Nalu Medical closes US$85 million Series E financing round

Nalu Medical has announced the closing of an incremental US$20 million in equity financing from new investor B Capital, bringing its total Series E...

US study finds link between social factors and intravenous thrombolysis rate

For ischaemic stroke patients, social factors like education, neighbourhood and employment may be linked to whether they receive treatment with intravenous, clot-busting drugs, according...

Medtronic files complaint against Axonics to stop “unauthorised use” of neuromodulation...

Medtronic recently announced that it has filed a complaint with the US International Trade Commission (ITC), along with a parallel action in US District...

Silk Road expands TCAR portfolio with launch of tapered Enroute system

Silk Road Medical has announced the launch of its tapered Enroute transcarotid stent system to hospitals in the USA, expanding upon the company’s prior...

Artiria secures funding to support completion of stroke studies in Europe...

Artiria Medical has announced the successful closing of a Series A2 round worth US$6 million and the securing of a US$600,000 Fit Tech Growth...

ISC 2024 examines TCAR ‘explosion’ alongside advances in intensive medical therapy

This year’s International Stroke Conference (ISC; 7–9 February, Phoenix, USA) hosted discussions on the current state of play in carotid stenosis treatment—and, most notably,...

Onward Medical awarded US FDA Breakthrough Device designation for ARC-BCI system

Onward Medical announced recently that it has been awarded Breakthrough Device designation (BDD) by the US Food and Drug Administration (FDA) for the ARC-BCI system, which...

No-reflow in clinical studies: Causes, rates and implications for patient outcomes

In a guest article for NeuroNews, Adnan Mujanovic (Bern, Switzerland) discusses a relatively unknown but potentially significant factor in stroke patients experiencing poor clinical...

One-year TESLA and SELECT2 data favour thrombectomy in large-core stroke patients

One-year follow-up data from two randomised controlled trials (RCTs) evaluating mechanical thrombectomy in patients with ischaemic strokes caused by large-core infarct volumes have demonstrated...

ASTER2 analysis links combined thrombectomy approach to improved reperfusion in proximal...

A subgroup analysis of the ASTER2 clinical trial has found that a first-line combined thrombectomy approach, which involves using contact aspiration and a stent...

Tivic completes enrolment in study of non-invasive, bioelectronic VNS therapy

Tivic Health Systems has announced that enrolment in its pilot clinical study of a proprietary approach to non-invasive vagus nerve stimulation (VNS) has been completed....

New trial tests electrical stimulation for treatment retention in opioid use...

The University of Cincinnati’s Center for Addiction Research and Spark Biomedical have jointly announced that they are conducting a clinical trial to help patients...

Route 92 completes enrolment in 250-patient SUMMIT MAX trial

Route 92 Medical has today announced the completion of enrolment in the 250-patient SUMMIT MAX clinical trial evaluating the safety and effectiveness of its...

Brain stimulation plus rehabilitation produces improved upper-limb function in stroke survivors

Combining brain stimulation with intense physical rehabilitation helped stroke survivors recover movement in their arms and hands, and maintain these improvements for one year, within a...

Reteplase demonstrates superiority to alteplase in acute ischaemic stroke trial

Reteplase has demonstrated potential as an alternative to alteplase in patients requiring intravenous thrombolysis (IVT) to treat acute ischaemic stroke, as per the findings...

SNIS acknowledges “major shift” in chronic SDH treatment following new trial...

In an official statement, the Society of Neurolnterventional Surgery (SNIS) has acknowledged middle meningeal artery (MMA) embolisation as a beneficial adjunctive treatment for chronic...

Addition of MMA embolisation reduces haematoma recurrence or progression in MAGIC-MT...

The use of middle meningeal artery (MMA) embolisation alongside standard care has been deemed superior to standard care alone for patients with symptomatic, non-acute...

Dual-stent retriever strategy demonstrates promise in TWIN2WIN clinical trial

Late-breaking findings from the TWIN2WIN trial—presented recently at the International Stroke Conference (ISC; 7–9 February, Phoenix, USA)—have demonstrated the potential benefits of performing mechanical...

Viz.ai gains US FDA 510(k) clearance for intracerebral haemorrhage imaging algorithm

Viz.ai has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for its Viz Intracerebral Haemorrhage (ICH) Plus algorithm, which is intended...

RapidAI highlights TIMELESS trial publication among other key ISC 2024 presentations

RapidAI has announced the publication of TIMELESS—a randomised trial evaluating the use of tenecteplase in acute ischaemic stroke treatment—in the New England Journal of Medicine...

Mainstay receives expanded MRI labelling from US FDA for ReActiv8 system

Mainstay Medical has announced that the US Food and Drug Administration (FDA) has approved full-body magnetic resonance imaging (MRI) conditional labelling for the ReActiv8...

STEM study finds improved outcomes with MMA embolisation over standard care...

Recently presented results from the STEM randomised controlled trial (RCT) have demonstrated improved outcomes with middle meningeal artery (MMA) embolisation plus standard management—as compared...

ZODIAC trial reveals clinical benefits of zero-degree head positioning prior to...

Laying large vessel occlusion (LVO) ischaemic stroke patients flat with their heads at a zero-degree angle prior to a mechanical thrombectomy procedure has resulted...

Sensome initiates trial assessing tissue microsensor technology in peripheral artery disease

Sensome has announced enrolment of the first patients into a feasibility clinical study using the Clotild smart guidewire in peripheral artery disease (PAD). Clotild was...

MMA embolisation plus surgery reduces risk of subdural haematoma recurrence in...

Middle meningeal artery (MMA) embolisation—the injection of a liquid embolic substance to block an artery feeding the brain’s dura—along with surgery for subacute or...

Cerenovus launches next-generation Cereglide 71 catheter for ischaemic stroke revascularisation

Cerenovus, part of Johnson & Johnson MedTech, has announced the launch of its Cereglide 71 device—a next-generation intermediate catheter with TruCourse technology indicated for...

AI-based decision support system helps improve post-stroke vascular outcomes at three...

Ischaemic stroke survivors who received care recommendations from an artificial intelligence (AI)-based system experienced fewer recurrent strokes and heart attacks, and a lower rate...

Measuring plaque inflammation via SCAIL scores may improve carotid stenosis risk...

The use of a relatively novel scoring system, referred to as Symptomatic carotid atheroma inflammation lumen-stenosis (SCAIL), has produced favourable predictive qualities versus the...

Halted MOST trial finds no benefit when adding blood thinners to...

Giving blood thinners in addition to clot-busting medications does not improve ischaemic stroke patients’ outcomes at 90 days, according to findings from the MOST trial, which...

New AHA statement seeks to improve recognition and management of cerebral...

A new scientific statement from the American Heart Association (AHA) emphasises the need to boost patient and physician awareness of cerebral venous thrombosis (CVT),...

Boston’s WaveWriter SCS systems gain expanded non-surgical back pain indication from...

Boston Scientific Corporation announced today that the US Food and Drug Administration (FDA) has approved an expanded indication of the company’s WaveWriter spinal cord...

New UK NICE guidance endorses AI-derived software in stroke assessments

A new guidance document from the UK National Institute of Health and Care Excellence (NICE) has endorsed National Health Service (NHS) deployment of two...

Carthera enrols first patient in trial assessing novel recurrent glioblastoma treatment

Carthera has announced the enrolment of the first patient in the SONOBIRD pivotal trial assessing its ultrasound-based Sonocloud medical device for the treatment of...

Advancing neurosurgery inside and outside the operating room

Brian Nahed (Boston, USA) outlines the latest advances in neurosurgery, and why it is important for those working in the field to keep up...

Lumosa, CHI Memorial announce new studies of stroke drug combining clot-busting...

Lumosa Therapeutics, in collaboration with CHI Memorial (Chattanooga, USA), has announced the initiation of multiple Phase 2 clinical trials for LT3001, which the company...

Synchron acquires equity stake in Acquandas

Endovascular brain-computer interface (BCI) technology firm Synchron has announced the acquisition of an equity stake in Acquandas—a leading technology provider specialising in state-of-the-art, high-precision components...

Ceroflo raises €6.4 million to aid progress of novel ICAD stroke...

Irish medical device firm Ceroflo announced today that it has raised €6.4 million in investment-round funding, which will be used to advance development of...

NeuroNews’ top 10 most popular stories of January 2024

A tribute to the late Conrad Yiu was NeuroNews’ most read story in January, indicating the impact he has had and will likely continue...

Basking Biosciences closes US$55 million financing to further reversible stroke thrombolytic

Basking Biosciences has announced the close of US$55 million in financing, which will be used to accelerate clinical development of its novel thrombolytic therapy...

Medtronic announces first neurointerventional case with CE-marked Rist 6Fr radial access...

Medtronic has announced the first neurointerventional case in Europe with its Rist 6Fr radial access catheter, which recently received regulatory approval for use in...

Low-dose ionising radiation may be “promising therapeutic strategy” in TBI and...

A research team led by City University of Hong Kong (CityU; Kowloon, Hong Kong) neuroscientists recently discovered that low-dose ionising radiation (LDIR), such as...

InspireMD receives CE-mark recertification under new EU regulatory framework

InspireMD announced today that it has received CE-mark recertification under the European Union’s (EU) new Medical Device Regulation (MDR) regulatory framework for its CGuard...

Abbott launches Liberta RC deep brain stimulation system with remote programming...

Abbott recently announced that it has received approval from the US Food and Drug Administration (FDA) to launch the Liberta RC deep brain stimulation...

Researchers detail “more elegant” DBS approach for improving Parkinson’s symptoms

A team of physicians, neuroscientists and engineers at Duke University (Durham, USA) have reported multiple new strategies that use deep brain stimulation (DBS) to...

Stroke experts divided over concluding messages from SEGA trial results

The closing weeks of 2023 saw fresh findings comparing general anaesthesia (GA) to sedation in stroke thrombectomy disclosed for the first time, with leading...

Thanh N Nguyen becomes first woman to serve as SVIN president

Thanh N Nguyen
Thanh N Nguyen, professor of neurology, radiology and neurosurgery at the Boston University Chobanian and Avedisian School of Medicine in Boston, USA, has been...

Leica Microsystems launches evolved version of ARveo 8 digital neurosurgery microscope

Leica Microsystems has launched an evolved version of its ARveo 8 digital visualisation microscope for neurosurgery. The ever-growing ecosystem, ARveo 8, enhances surgical visualisation...

Canadian hospital uses “world’s smallest camera” to see inside stroke patient’s...

Physicians at The Ottawa Hospital (TOH) in Ottawa, Canada recently became the first in the world to use a new stroke technology, the MicroAngioscope...

Nalu Medical presents long-term, holistic outcomes with PNS system at NANS...

Nalu Medical presented interim data from the “landmark” COMFORT randomised controlled trial (RCT)—indicating long-term and holistic pain management outcomes with its peripheral nerve stimulation...

Medtronic announces trial data on closed-loop and DTM SCS therapies at...

At this year’s North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas, USA), Medtronic announced new data from two clinical trials demonstrating...

Cerevasc highlights eShunt study presentations from ABC WIN Seminar

Cerevasc has announced that data from clinical studies in the USA and Argentina examining the use of its eShunt system to treat communicating hydrocephalus were presented at...

Female hormone intake and its influence on cerebral cavernous malformations

As per an observational study published in the journal Neurology last year, female hormone therapy use may be associated with a higher risk of...

Midterm CARAS study results show cerebral ischaemic event incidence “should not...

The final publication of midterm results from the observational CARAS study suggest that cerebral ischaemic event (CIE) incidence in asymptomatic carotid stenosis patients “should...

Boston Scientific announces positive WaveWriter SCS findings from SOLIS trial

Boston Scientific Corporation has announced positive one-year results from the SOLIS randomised controlled trial, demonstrating sustained pain relief using its WaveWriter Alpha spinal cord...

Abbott gains expanded MRI labelling from US FDA for Proclaim DRG...

Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its dorsal root ganglion...

Arissa Medical enrols first patients in first-in-human Syntra study

Arissa Medical has announced the enrolment of the first patients in its Syntra study—a first-in-human (FIH), early feasibility study evaluating the safety and efficacy...

Latest Pipeline Vantage device produces “acceptable outcomes” in unruptured aneurysms

A new study, published in the Journal of NeuroInterventional Surgery (JNIS) late last year, has assessed the safety of the latest iteration of the...

Medtronic gains US FDA approval for Percept RC deep brain stimulation...

Medtronic has announced the US Food and Drug Administration (FDA) approval of its Percept RC deep brain stimulation (DBS) system. The rechargeable neurostimulator is the...

Nevro to highlight 25 scientific abstracts on spinal cord stimulation at...

Nevro Corporation has announced a series of data presentations supporting the use of the company's high-frequency (HFX) 10kHz spinal cord stimulation (SCS) therapy for...

Saluda announces plans to present new EVOKE study data at NANS...

Saluda Medical has announced that its data will be presented at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las Vegas,...

SPR Therapeutics announces multiple first-time data presentations set for NANS 2024

SPR Therapeutics has announced that it is set to be featured prominently at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January, Las...

Boston Scientific to present late-breaking data at NANS 2024

Boston Scientific Corporation has announced its clinical data that will be featured at the upcoming North American Neuromodulation Society (NANS) annual meeting (18–21 January,...

Route 92 announces 100th patent for its neurovascular intervention portfolio

Route 92 Medical has announced the company’s 100th global issued patent for its innovative neurovascular intervention product portfolio, as per a press release. The...

Neuralace announces US FDA clearance for Axon therapy ahead of NANS...

Neuralace Medical has announced the US Food and Drug Administration (FDA) clearance of its “groundbreaking” Axon therapy for the treatment of chronic painful diabetic...

No increased risk of complications found with transradial access for carotid...

Carotid artery stenting (CAS) delivered via transradial artery access has demonstrated no increased risk of stroke, death, myocardial infarction, transient ischaemic attack, or access...

Black people face strokes at higher rates and younger ages than...

In a recent study from the USA now published in the journal Neurology, Black people consistently had a higher rate of stroke than white...

Arissa Medical announces positive feasibility study results with Syntra intrasaccular scaffold

Arissa Medical has announced the successful evaluation of the Syntra intrasaccular scaffold system within simulated use conditions under fluoroscopy using clinically relevant, in-vitro intracranial...

Mentice gains US FDA 510(k) clearance for Ankyras software

Mentice recently announced that Ankyras, the company’s clinical decision support application, has received 510(k) clearance from the US Food and Drug Administration (FDA). The...

Newly published PROST trial results find Preset non-inferior to Solitaire in...

Final results from the PROST randomised controlled trial (RCT) have been published in JAMA Neurology and—according to the study’s leading investigators—provide evidence that thrombectomy...

Is it time to consider a paradigm shift from mechanical thrombectomy...

In light of recent evidence indicating that thrombectomies with poor reperfusion may lead to inferior clinical outcomes versus medical management in ischaemic stroke, Adrien...

Hyperfine launches AI-powered eighth generation of Swoop system software

Hyperfine has announced the launch of the artificial intelligence (AI)-powered eighth generation of its Swoop system software. “The software update on the Swoop system has been...

“The third way” in intrasaccular aneurysm treatment demonstrates positive one-year outcomes

galaxy seal device
A device labelled “the third way” to potentially treat intracranial aneurysms via an intrasaccular approach has demonstrated positive effectiveness and safety results at one...

Question is “not if, but when” to stent in challenging, NET-rich...

The recent Barts Research and Advanced Interventional Neuroradiology (BRAIN) conference (4–6 December 2023, London, UK) saw Tommy Andersson (Karolinska University Hospital, Stockholm, Sweden) put...

Phil White

Phil White’s career as a physician and researcher has seen him play a role in numerous major stroke trials, and serve as an educator...

Axonics announces definitive agreement to be acquired by Boston Scientific

Axonics has announced that it has entered into a definitive agreement to be acquired by Boston Scientific Corporation for US$71 in cash per share,...

SynerFuse appoints Rohan Lall as chief medical officer

SynerFuse has announced the appointment of Rohan Lall (M Health Fairview Neurosurgery, Princeton, USA) as the company’s chief medical officer. The appointment was effective...

Rescue stenting shows good outcomes among Middle Eastern, African and Asian...

Rescue stent placement following a failed thrombectomy procedure has demonstrated “good outcomes” and a low risk of clinically significant bleeding in a multiethnic cohort...

Evasc announces clinical milestones and plans to expand European presence with...

Evasc Neurovascular has announced new strategic growth initiatives, having recently achieved a milestone of 120 successful cerebral aneurysm cases with its innovative Eclips device....

NeuroNews’ top 10 most popular stories of December 2023

Multiple new pieces of major trial data presented at the Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November 2023, Miami, USA)...

Global experts call for tighter standards to speed up emergency haemorrhagic...

An international panel of clinical researchers has published a report in the journal Stroke in which they advocate “immediate change” regarding treatment protocols for...

NeuroPace announces early completion of patient enrolment in NAUTILUS pivotal study

NeuroPace has announced the completion of the patient enrolment goal in its NAUTILUS pivotal study for the treatment of idiopathic generalised epilepsy (IGE) “more...

US neurointerventionists argue recent data “affirm” benefits of direct stroke triage

In an editor's column published recently in the Journal of NeuroInterventional Surgery (JNIS), leading members of the Society of NeuroInterventional Surgery (SNIS) have argued that the entire body...

Perfuze announces US FDA 510(k) clearances for novel aspiration and access...

Perfuze has announced US Food and Drug Administration (FDA) clearances for the Millipede 070 aspiration catheter and the second-generation of its Millipede 088 access...

Ischaemic stroke—we are all vulnerable

Conrad Yiu
Conrad Yiu, a pioneer and visionary in interventional ischaemic stroke therapy, passed away in the final weeks of 2023, succumbing to the very disease for...

Researchers receive €10 million grant to create ‘digital twins’ in cerebral...

Researchers in The Netherlands have received a Horizon grant worth €10 million from the European Commission to accelerate development of a technology that could...

Nicolab attains US FDA 510(k) clearance for CT perfusion algorithm

Nicolab has announced that its computed tomography (CT) perfusion algorithm, which is integrated into the company’s StrokeViewer platform, has obtained 510(k) clearance from the...

Former Stimwave CEO hit with fraud charges over ‘fake, non-functional’ device...

The US Securities and Exchange Commission (SEC) has today charged Laura Tyler Perryman—the former chief executive officer (CEO) and co-founder of Florida-based medical device...

INSPIRE-S registry offers comprehensive, real-world data on acute ischaemic stroke devices

This advertorial is sponsored by Medtronic. As part of the company’s ongoing commitment to offering physicians access to high-quality clinical data and, subsequently, enabling evidence-based...

Washington state “poised” to extend spinal cord stimulation coverage following straw...

As per a recent statement from the North American Neuromodulation Society (NANS), the US state of Washington may be about to extend its insurance...

Imperative announces FIH study of device enabling single antiplatelet therapy after...

Imperative Care has announced the initiation of a first-in-human (FIH) clinical study for its novel stent system designed to only require single antiplatelet therapy...

APRO catheters offer ‘gold-standard’ trackability with robustness and stent-retriever compatibility to...

This advertorial is sponsored by Medtronic. As the co-founder and chief executive officer of Chestnut Medical, Aaron Berez played a leading role in bringing flow...

MRI-equipped ambulances could help speed up acute stroke diagnoses and treatments

Researchers from the Medical University of South Carolina (MUSC) have partnered with US emergency medical services (EMS) to pilot test the first magnetic resonance...

NeuroOne receives US FDA 510(k) clearance to market OneRF ablation system

NeuroOne Medical Technologies Corporation has announced that it has received US Food and Drug Administration (FDA) 510(k) clearance to market its OneRF ablation system for...

Neuspera completes patient enrolment and implants for SANS-UUI pivotal clinical trial

Neuspera Medical recently announced it has completed patient enrolment and implant procedures for the SANS-UUI pivotal clinical trial of its Neuspera system—a discreet, minimally...

BCV secures €6 million in Series A funding round

BCV has announced that it has secured €6 million in a Series A round of financing led by Forepont Capital Partners, with other investors...

NeuroNews’ top 10 most popular stories of October/November 2023

Across October and November, our readers were drawn to everything from recent shifts in neurovascular device regulation, to “failures of the peer-review process” in...

Rapid announces Japanese approval and exclusive partnership with Kaneka for Tigertriever

Rapid Medical has announced Japanese approval for its Tigertriever revascularisation device. With Pharmaceuticals and Medical Devices Agency (PMDA) approval, Tigertriever serves as “the first...

INSPIRE-A registry helps pave way for standardised assessment of flow-diverter imaging...

This advertorial is sponsored by Medtronic. As a prospective, independently adjudicated registry boasting a highly comprehensive patient dataset, INSPIRE-A is a “very unique” phenomenon in...

Philips enrols 100th patient in WE-TRUST study of direct-to-angio-suite approach

Philips has announced that, on 29 November 2023, the WE-TRUST study enrolled its 100th patient, marking what the company describes as an “important milestone”...

NeuroNews issue 52 – US

Highlights: Physicians posit that equipoise likely remains between general anaesthesia and conscious sedation in endovascular therapy following the presentation of SEGA trial results at...

NeuroNews issue 52 – OUS

Highlights: Physicians posit that equipoise likely remains between general anaesthesia and conscious sedation in endovascular therapy following the presentation of SEGA trial results at...

SpineX close to full recruitment for SCONE clinical trial

SpineX has announced that it is close to full recruitment of the patient cohort for a clinical trial of its proprietary SCONE device, recently...

Q’Apel Medical launches new-generation Hippo aspiration system for stroke thrombectomy

Q’Apel Medical has launched a new-generation aspiration technology, the 072 Hippo aspiration system, which has been developed for patients suffering from a stroke due...

New SOFAST data show high technical success and first-pass rates with...

Fresh data from the SOFAST study have indicated high rates of technical success and first-pass reperfusion with the Sofia 6Fr Flow Plus aspiration catheter...

Nevro announces acquisition of Vyrsa Technologies

Nevro Corporation has announced that it has acquired Vyrsa Technologies—a privately held medical technology company focused on a minimally invasive treatment option for patients...

Stroke thrombectomy gains approval from Brazilian health ministry in “historical milestone”

A “historical milestone” for stroke patients in Brazil was achieved recently, with the country’s Ministry of Health (MOH) publishing Order 1.996/2023 on 24 November...

Neurovascular OBLs: Business outcomes, patient outcomes, and reimbursement trends

This advertorial, sponsored by Siemens Healthineers and intended for US readers only, is part of a series of articles on the emerging role for...

Nalu announces positive results from spinal cord stimulation nPower US clinical...

Nalu Medical has announced the publication of the spinal cord stimulation (SCS) nPower US clinical study in the Pain Physician Journal, reporting on clinical outcomes...

Study finds “eye-opening” variability across physician estimations of flow-diverter deployment

A comparative study recently demonstrated the promise held by PreSize Neurovascular (Oxford Heartbeat) software in consistently and accurately making predictions about flow-diverter placement in...

Tenecteplase deemed a safe and feasible adjunct to thrombectomy in ALLY...

Intra-arterial tenecteplase has demonstrated potential as a safe and feasible adjunct to mechanical thrombectomy in patients with acute ischaemic stroke caused by a distal...

Newly published study shows preventative benefits of Nerivio wearable in adolescents...

Theranica has announced the peer-reviewed publication of a comprehensive clinical study showing the preventive benefits of its remote electrical neuromodulation (REN) wearable, Nerivio, for...

Understanding brain aneurysms: Prevalence, burden, and empowering patients

In a guest piece for NeuroNews, Arūnė Simanavičienė (Kaunas, Lithuania) and Audrius Širvinskas (Vilnius, Lithuania) highlight the work being done by the Brain Aneurysm...

Endovascular therapy under general anaesthesia linked to improved functional outcomes versus...

The multicentre, randomised SEGA trial has found that acute ischaemic stroke patients who receive endovascular therapy (EVT) under general anaesthesia experience better functional outcomes...

Apotransferrin shows promise in animal models of intracranial haemorrhage

Researchers from Germans Trias i Pujol Research Institute (IGTP; Badalona, Spain) have discovered that administering human apotransferrin to mice affected by intracranial haemorrhage (ICH)...

Mobile stroke units increase odds of averting strokes and achieving complete...

Receiving intravenous tissue plasminogen activator (IV-tPA) in an ambulance-based mobile stroke unit (MSU) increases the likelihood of averting strokes and the odds of a...

Brainomix targets US expansion following launch of 360 platform at SVIN...

Brainomix has heralded its continued US expansion with the launch of a full suite of US Food and Drug Administration (FDA)-cleared modules in its...

Nevro announces “profound improvements” in non-surgical refractory back pain patients treated...

Nevro Corporation has announced the publication of new 24-month data from the SENZA-NSRBP multicentre randomised controlled trial (RCT) in the Journal of Neurosurgery: Spine. The...

Route 92 raises more than US$31 million in oversubscribed Series F...

funding
Route 92 Medical has announced it has raised more than US$31 million in a Series F financing round to accelerate the commercial adoption of...

Neurolutions and Kandu partner to accelerate access to improved stroke rehabilitation

Neurolutions and Kandu Health recently announced a strategic partnership intended to raise the standard of care for post-stroke recovery. Through this partnership, Kandu’s expert...

Boston Scientific expands neuromodulation portfolio with Relievant Medsystems acquisition

Boston Scientific Corporation has announced the close of its acquisition of Relievant Medsystems—the company behind the US Food and Drug Administration (FDA)-cleared Intracept intraosseous...

Tenecteplase deemed non-inferior to alteplase in suitable ischaemic stroke patients

The ATTEST-2 trial has found that tenecteplase was non-inferior to alteplase, the more established of the two thrombolytic agents, in suitable acute ischaemic stroke...

Tigertriever device produces high treatment-success rate in challenging ICAD stroke patients

Rapid Medical has announced new data demonstrating “excellent” first-pass treatment success using the Tigertriever device in complex ischaemic stroke patients with underlying intracranial atherosclerotic disease (ICAD)....

Microvention celebrates 10 years and more than 500,000 procedures with Sofia...

Microvention, a wholly owned subsidiary of Terumo Corporation, is celebrating a decade of legacy innovation commemorating the anniversary of its Sofia and Sofia Flow...

Route 92 announces positive clinical findings with Tenzing 7 delivery catheter

Route 92 Medical has announced new results from a multicentre clinical study evaluating the efficacy, safety and efficiency of the Tenzing 7 delivery catheter as a...

Current intracranial aneurysm literature reflects “a failure of the peer-review process”

A systematic review and meta-analysis of 1,356 studies and more than 410,000 patients have found that “methodological flaws and incomplete reporting” occur frequently in...

Evolving the standard of care: What is next for functional neurosurgery?

The proliferation of new technologies and advancements in the neurosciences space has showed little sign of slowing in recent years and—as John Rolston (Boston,...

CX 2024: New technologies and “special cases” underpin carotid and acute...

With a renewed focus on challenging cases, novel technologies and, overall, the most pressing issues in carotid treatments and acute stroke care, the 2024...

Patients in lower socioeconomic status areas less likely to receive acute...

People who live in neighbourhoods with lower socioeconomic status are less likely to receive clot-busting medications or undergo mechanical thrombectomy procedures after they have...

SpineX announces new report on SCS improving bladder function in stroke...

SpineX has reported in a press release that a publication titled, “A pilot study of the effect of transcutaneous spinal cord stimulation on micturition-related...

RapidAI receives US FDA clearance of AI module for detecting hemispheric...

RapidAI announced today that it has received US Food and Drug Administration (FDA) clearance for Rapid SDH, its artificial intelligence (AI)-powered module for the detection...

Rapid Medical announces enrolment of final patient in post-market SUCCESS study

Rapid Medical has announced that the final patient has been enrolled in SUCCESS—a US Food and Drug Administration (FDA) post-market surveillance study assessing the...

Medical necessity “should drive all remote monitoring decisions” in SCS, expert...

The principle of medical necessity “should drive all remote monitoring decisions” relating to spinal cord stimulation (SCS) technologies, according to recommendations recently published in...

Surgical Information Sciences initiates VISION study to support DBS for Parkinson’s...

Surgical Information Sciences (SIS) has announced the commencement of its post-market VISION study evaluating visualisation of the subthalamic nucleus (STN) and globus pallidus internus...

Perfuze enrols first stroke patient in MARRS pivotal trial of Millipede...

perfuze millipede 088
Perfuze has announced commencement of enrolment in its pivotal MARRS study—a multicentre trial set to evaluate the performance of aspiration thrombectomy with the company’s...

InspireMD presents positive 30-day follow-up results from C-GUARDIANS clinical trial

InspireMD recently presented 30-day results from the C-GUARDIANS US investigational device exemption (IDE) clinical trial evaluating its CGuard embolic prevention stent (EPS) system for...

TENSION results show improved functional outcomes and reduced mortality with stroke...

New results from the TENSION study—presented recently at the 15th World Stroke Congress (WSC; 10–12 October, Toronto, Canada) by Götz Thomalla (University Medical Center...

Contego announces low one-year stroke rates in PERFORMANCE II carotid stent...

Contego Medical has announced the presentation of late-breaking clinical results from the PERFORMANCE II carotid stent trial at the annual Vascular Interventional Advances (VIVA)...

Annalise.ai launches comprehensive radiology triage suite for chest X-ray and head...

Annalise.ai has announced the launch of Annalise Triage—an innovative software solution tailored specifically for the US market that the company claims will “transform the...

NICO highlights study showing “first ever” successful deep-brain BCI implantation in...

A study demonstrating the successful deep-brain placement of a brain-computer interface (BCI) microchip into a living animal with no apparent neurological effects has been...

SVIN 2023 to champion innovation and inclusivity in “notable departure” from...

In a “notable departure” from prior iterations of the conference, this year’s Society of Vascular and Interventional Neurology (SVIN) annual meeting (16–18 November, Miami,...

PROST represents “epitome” of scientific rigour, but future trials may follow...

There are multiple components of the PROST randomised controlled trial’s (RCT) design that set it apart from prior studies and make it somewhat unique...

Surmodics launches Preside hydrophilic coatings for neurovascular, coronary and peripheral applications

Surmodics has announced the commercial launch of its most advanced hydrophilic medical device coating technology, the Preside hydrophilic coatings. As per a company press release,...

MindRhythm receives US FDA breakthrough designation for Harmony headset

MindRhythm has announced that the US Food and Drug Administration (FDA) has awarded a Breakthrough Device designation to its Harmony headset embedded with HeadPulse...

No relationship found between DW-MRI lesions and long-term stroke risk following...

A secondary analysis of existing clinical trial data has indicated that new ischaemic brain lesions detected via diffusion-weighted magnetic resonance imaging (DW-MRI) following carotid...

Case report details “promising” first use of bilateral cerebellar rTMS to...

In a new case report, researchers at University of California Los Angeles (UCLA) Health have described “promising results” using repetitive transcranial magnetic stimulation (rTMS)...

Latest TRIAGE-STROKE and RACECAT data put the brakes on alternative stroke...

Recently published data from two large randomised controlled trials (RCTs) have indicated there may be minimal benefits—or even negative effects—associated with bypassing local or...

Cordance gains US FDA breakthrough designation for NeuroAccess technology

Cordance Medical has announced that its device, NeuroAccess, has been granted Breakthrough Device designation by the US Food and Drug Administration (FDA), meaning the...

Physicians highlight that “stroke strikes at any age” ahead of World...

Ahead of World Stroke Day 2023, on 29 October, physicians from the Get Ahead of Stroke campaign are highlighting the fact that, while prevalence...

EOSolutions receives US FDA clearance for Thinline introducer sheath

EOSolutions Corporation has announced that the US Food and Drug Administration (FDA) has cleared its Thinline introducer sheath—an approval that swiftly follows the successful...

Cognito announces 18-month data showing durability of gamma sensory stimulation for...

Cognito Therapeutics has announced that continued active treatment with the company’s gamma sensory stimulation technology in the Phase 2 OVERTURE open label extension (OLE)...

Butterfly Network and Forest Neurotech to partner on development of next-generation...

Digital health company Butterfly Network and deep tech research firm Forest Neurotech announced yesterday that they have entered into a five-year co-development agreement to...

Upcoming technologies set to forebear “new era” in prehospital stroke care

While the latest thrombectomy techniques, thrombolytic drug candidates and even neuroprotective agents are the source of much discussion in today’s neurovascular space, there is...

Researchers develop non-surgical DBS technology capable of boosting memory accuracy

Researchers at the UK Dementia Research Institute (DRI) have developed a new form of deep brain stimulation (DBS) that does not require surgery and...

Smart ‘brain-wave cap’ could help diagnose stroke patients accurately in ambulances

A specialised ‘brain-wave cap’, designed by researchers in The Netherlands, may be able to diagnose stroke patients while they are in an ambulance—thus allowing...

Robocath completes CARE clinical trial evaluating robotic carotid stenting

Robocath has today announced the results of its CARE clinical trial focusing on robotic carotid stenting—the first phase of a research programme launched in...

SynerFuse completes enrolment in proof-of-concept study

SynerFuse has announced that it has completed enrolment in its proof-of-concept study to evaluate the safety and tolerability of the Electric Transforaminal Lumbar Interbody...

Expert roundtable devises roadmap on fatigue, mobility, brain stimulation and research...

The third Stroke Recovery and Rehabilitation Roundtable—an initiative of the International Stroke Recovery and Rehabilitation Alliance (ISRRA)—has made a series of key recommendations about...

Current evidence on AI-based autonomous interventions “inadequate” despite potential benefits

The existing body of evidence supporting artificial intelligence (AI) and the autonomous navigation of endovascular procedures is “inadequate”, despite the theoretical benefits held by...

Bilateral cerebellar rTMS represents “promising” treatment option for post-stroke dysphagia

Administering 10Hz cerebellar repetitive transcranial magnetic stimulation (rTMS) offers a “promising”, non-invasive treatment option in patients experiencing dysphagia following a subacute infratentorial stroke, as...

Anaconda Biomed granted additional patents for novel stroke thrombectomy technology

Anaconda Biomed has announced that the European Patent Office has granted the company a European patent for “A device and a thrombectomy apparatus for...

New data suggest faster and less costly thrombectomy procedures with Zoom...

Imperative Care recently announced the publication of clinical data in the journal Interventional Neuroradiology (INR) detailing the use of its Zoom aspiration catheters in...

Athersys announces ‘disappointing’ results from MASTERS-2 interim analysis

Athersys has announced that the independent data safety monitoring board (DSMB) has completed a preplanned interim analysis of the company’s ongoing, phase three MASTERS-2...

“The tables have turned”—US FDA regulation is becoming the envy of...

Discussions at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) revealed the extent of the disparities between the...

Nautilus represents “next evolution” of intrasaccular systems in aneurysm care

The Nautilus system (Endostream Medical)—a self-conforming intrasaccular flow diverter intended for the treatment of intracranial aneurysms—heralds the “next evolution” in these types of neurovascular...

Boston receives expanded US FDA approval of SCS therapy for painful...

Boston Scientific has announced that the US Food and Drug Administration (FDA) has approved an expanded indication of the WaveWriter Alpha spinal cord stimulator...

Brainomix and Nanoflex to work on AI-assisted robotic system for remote...

Brainomix and Nanoflex Robotics have announced today that they have been awarded a grant via the ‘UK—Switzerland Bilateral: Collaborative R&D ’ programme, under which...

Rates of stroke, death and myocardial infarction post-TCAR do not differ...

While sex disparities regarding the outcomes of carotid revascularisation have “long been a concern”, new prospective data published in the Journal of Vascular Surgery...

Newly published data indicate NovaGuide system can outperform standard of care...

NeuraSignal has announced the publication of positive results from the BUBL clinical study supporting the safety and superior performance of its NovaGuide intelligent ultrasound...

Philips partners with WSO to improve access to high-quality stroke care...

Royal Philips and the World Stroke Organization (WSO) have announced the signing of a two-year partnership aimed at improving access to high-quality stroke care. Building...

Hyperfine gains US FDA clearance for AI-powered software update of Swoop...

Hyperfine has announced US Food and Drug Administration (FDA) clearance of updated software for its portable magnetic resonance brain imaging technology, the Swoop system....

WSO predicts 50% more deaths unless “catastrophic” gaps in global stroke...

Between now and 2050—unless “urgent action is taken”—the number of people who die from stroke globally is estimated to increase by 50%, to 9.7...

Contego announces enrolment of first patient in PERFORMANCE III trial

Contego Medical has announced enrolment of the first patient in the prospective, multicentre PERFORMANCE III trial aimed at further evaluating the safety and effectiveness...

NeuroNews’ top 10 most popular stories of September 2023

Exclusive interviews with multiple pioneering figures in the US neurovascular field earmark NeuroNews’ latest top 10, as do results from two ongoing studies attempting...

Biotronik announces new data supporting effectiveness of RESONANCE multiphase stimulation paradigm

Biotronik Neuro has announced that results from the BENEFIT-02 trial—the “first of its kind” to clinically evaluate a multiphase stimulation paradigm—support the effectiveness of...

‘Surprising’ regional variations in subarachnoid haemorrhage care revealed by Finnish study

A study recently published in the journal Neurology investigated whether there are discrepancies in the prognosis of subarachnoid haemorrhage (SAH) patients between the university hospital...

Medtronic names Paolo Di Vincenzo president of its neuromodulation business

Medtronic has shared that Paolo Di Vincenzo will join the company as president of its neuromodulation business, effective 30 October 2023. In this role,...

NANS leads multi-society response to “methodologically flawed” SCS re-review in Washington...

The North American Neuromodulation Society (NANS) has led a multi-society response to the Washington State Health Care Authority (WSHCA) following its review of the...

Reduced complications and patient satisfaction among key benefits of radial access

Transradial access, whereby the vasculature is navigated to via the radial artery in the wrist, has been a topic of much debate in the...

Research shows “direct mechanistic link” between COVID-19 infection and heart attack,...

A new study has shed fresh light on the potential connection between pre-existing heart issues and symptoms of ‘long-COVID’. According to researchers from New...

Striving for more distal guide-catheter placement is a “no-brainer” in stroke...

This advertorial, intended for US readers only, is sponsored by CERENOVUS. “Going distally with guide catheters is more routine nowadays,” says Violiza Inoa (Memphis, USA),...

Young neurosurgeon awarded US$150,000 to study higher cerebral aneurysm rate in...

A young neurosurgeon and researcher from Buffalo, USA has been awarded US$150,000 via the Congress of Neurological Surgeons (CNS) Foundation/Cerebrovascular (CV) Young Investigator Grant...

Remote teleproctoring helps neurointerventionists overcome wartime restrictions in Ukraine

Remote teleproctoring has demonstrated promising results in providing hands-on mechanical thrombectomy training and overcoming wartime migration restrictions in Ukraine, according to initial experiences published...

NeuroNews issue 51 – US

Highlights: New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from...

NeuroNews issue 51 – OUS

Highlights: New data that "refute" the seminal ARUBA trial's conclusions on interventional treatments for arteriovenous malformations (AVMs) as well as several other highlights from...

Recent breakthroughs represent “baby steps” towards wider use of brain-computer interfaces

“The possibility to restore mobility to patients could have tremendous benefits,” says Mitchell Elkind, chief clinical science officer of the American Heart Association (AHA),...

Cerevasc announces multiple data presentations from CNS 2023

Cerevasc has announced that data from clinical studies examining the use of its eShunt system to treat elderly patients with normal-pressure hydrocephalus, and patients with...

Saluda receives US FDA approval for MRI labelling of Evoke spinal...

Saluda Medical has announced that the US Food and Drug Administration (FDA) has approved magnetic resonance imaging (MRI) conditional labelling for its Evoke system,...

Onward announces first-in-human implant of ARC-IM stimulator with wireless BCI device

Onward Medical has today announced the successful first-in-human implant of its ARC-IM stimulator intended to restore upper-extremity function after spinal cord injury (SCI). The...

US Brain Aneurysm Foundation announces 2023 research grants

The Brain Aneurysm Foundation (BAF) has announced the recipients of its 2023 research grants, providing support to academic researchers studying the underlying biology of aneurysms or...

New AVM intervention findings “refute” ARUBA complication rates and may elicit...

New data from an analysis of patients who would have been eligible for the ARUBA trial—which previously indicated medical management is likely favourable over...

Young endarterectomy patients more likely to experience restenosis and late neurological...

Data from the US Vascular Quality Initiative (VQI) have indicated that younger patients (aged ≤55 years) who undergo a carotid endarterectomy (CEA) procedure face an...

Cerevasc announces US FDA-approved expansion of normal-pressure hydrocephalus study

Cerevasc has announced that the US Food and Drug Administration (FDA) has approved an investigational device exemption (IDE) supplement to permit the expansion of...

Vesalio announces presentation of positive CLEAR study results at ESMINT 2023

Vesalio has announced the recent presentation of key findings from the CLEAR study—a prospective, multicentre, open-label, single-arm, US Food and Drug Administration (FDA)-regulated investigational...

Insights from interventional neuroradiologists on coping with severe complications

Given the potentially devastating consequences that can occur if an ischaemic stroke or acute intracranial aneurysm procedure goes wrong, an interventional neuroradiologist’s practice is...

Nevro announces new data demonstrating health economic benefits of 10kHz SCS...

Nevro Corporation has announced the publication of new data validating the health economic benefits of 10kHz therapy, the company’s proprietary, high-frequency spinal cord stimulation...

Microvention enters transradial access market with US FDA clearance of Sofia...

Microvention, a wholly owned subsidiary of Terumo Corporation, announced today that the Sofia EX 5Fr 115cm intracranial support catheter received US Food and Drug...

AI algorithm shows promise for early intracerebral haemorrhage detection in retrospective...

Sheba Medical Center in Tel Aviv, Israel has revealed the results from a “groundbreaking” study in the International Journal of Emergency Medicine, validating an...

ASA seeks to ‘empower’ Hispanic-Latino communities with promotion of RÁPIDO acronym

To help “close the gap between knowledge and action”, the American Stroke Association (ASA) is launching a culturally relevant Spanish-language campaign named ‘Juntos Contra...

Motif conducts first-in-human research of pea-sized brain stimulator for treatment-resistant depression

Motif Neurotech, a company developing minimally invasive bioelectronics for mental health conditions, has announced new research published to the preprint server Medrxiv that demonstrates the use...

Route 92 Medical announces appointment of Jonathan Kennedy as chief financial...

Route 92 Medical has announced the appointment of Jonathan Kennedy to the role of chief financial officer. In this role, Kennedy will be responsible...

Boston Scientific to expand neuromodulation portfolio with Relievant Medsystems acquisition

Boston Scientific Corporation has today announced it has entered into a definitive agreement to acquire Relievant Medsystems—a privately held medical technology company that has...

Cerevasc announces presentation of initial eShunt data at ESMINT 2023

Cerevasc has today announced that findings from a clinical study examining the use of its eShunt system to treat communicating hydrocephalus were recently presented...

Theranica announces new study indicating meaningful impact of Nerivio from as...

Theranica has announced the results of a study, recently published in the journal Pain Management, suggesting the rapid impact of Nerivio—the first and only...

New Pathway to Neurosurgery programme intends to “open doors” for underrepresented...

The Congress of Neurological Surgeons (CNS) Foundation has launched its Pathway to Neurosurgery programme, an initiative dedicated to alleviating healthcare disparities by encouraging high...

Brain Aneurysm Foundation launches ‘Stop the Pop’ campaign

stop the pop campaign
The Brain Aneurysm Foundation (BAF) has announced the launch of ‘Stop the Pop’—a new campaign intended to increase awareness of the prevalence and impact...

NeuroNews’ top 10 most popular stories of August 2023

Several presentations and news stories from this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) ended up among...

Synchron completes enrolment in US COMMAND trial of endovascular brain-computer interface

Synchron has announced completion of patient enrolment in the USA-based COMMAND trial assessing the company’s endovascular brain-computer interface (BCI) technology. “Giving patients the option to...

‘Minimal differences’ in clinical outcomes between stroke thrombectomy with or without...

There are likely to be minimal differences in clinical outcomes between acute stroke patients presenting directly to endovascular treatment centres who undergo mechanical thrombectomy...

Intrathecal drug delivery effective for managing cancer-related pain, as per existing...

Two separate systematic reviews and meta-analyses—both published recently in Neuromodulation: Technology at the Neural Interface—have concluded that intrathecal drug delivery (IDD) systems are effective...

Observation, creativity and happy accidents: Transitioning from clinical life to industry...

When it comes to advising young physicians on how to navigate the more commercial, industry-entwined commitments that their career will most likely bring further...

The physics of aspiration thrombectomy—what matters?

This advertorial, intended for readers outside the USA only, is sponsored by Penumbra. Much of the clinical success that can be achieved with aspiration-based mechanical...

Old but still gold—why coiling remains a vital tool for treating...

This advertorial is sponsored by Medtronic. Alberto Nania (National Health Service Lothian, Edinburgh, UK) speaks to NeuroNews to outline how, despite the rapid proliferation...

EVT with poor reperfusion linked to worse outcomes than medical management...

Endovascular therapy (EVT) treatments that achieve poor reperfusion have been found to result in inferior clinical outcomes compared to best medical management (BMM) in...

Rapid gains Chinese NMPA regulatory approval for Tigertriever thrombectomy device

Rapid Medical has announced Chinese National Medical Product Administration (NMPA) approval for its adjustable Tigertriever revascularisation device, making it the first device to offer...

Ameer Hassan

ameer hassan
Having initially sought out a career in plastic surgery, Ameer Hassan (Harlingen, USA) switched gears to interventional neurology in 2005—a change of heart he...

Mainstay Medical announces completion of US enrolment in RESTORE clinical trial

Mainstay Medical has announced the completion of enrolment in its RESTORE randomised clinical study of ReActiv8 for the treatment of intractable chronic low back...

Novel ‘infraslow pink noise’ stimulation found to be safe and feasible...

A novel brain stimulation technique called high-definition transcranial infraslow pink noise stimulation (HD-tIPNS) was recently evaluated in a placebo-controlled pilot study, and found to...

Brain Navi to showcase NaoTrac and KrystoLens neurosurgical devices at upcoming...

Brain Navi has announced the demonstration of NaoTrac, a neurosurgical navigation robot, and KrystoLens, a single-use neuro-endoscope, at two upcoming conferences: the Congress of Neurological...

Two-year data indicate long-term effectiveness of Nevro’s SCS therapy in painful...

Nevro Corporation recently announced the publication of 24-month data from the SENZA painful diabetic neuropathy (PDN) randomised controlled trial (RCT)—the largest RCT to evaluate...

Mahesh Jayaraman becomes 28th president of the Society of NeuroInterventional Surgery

Mahesh Jayaraman, an interventional neuroradiologist at Rhode Island Hospital in Providence, USA—who has led national efforts to improve stroke systems of care in the...

Medtronic receives CE-mark approval for Inceptiv closed-loop SCS to treat chronic...

Medtronic has received CE-mark approval for its Inceptiv closed-loop rechargeable spinal cord stimulator in the treatment of chronic pain. Inceptiv is the first Medtronic spinal...

Case series indicates effectiveness of direct-current stimulation in multiple sclerosis patients

A case series conducted by Courtney Ellerbusch (Centura Home Health, Colorado, USA) on multiple sclerosis (MS) patients has found quantitative improvements in strength, spasticity,...

Biomarker-guided neuromodulation alleviates memory loss in traumatic brain injury patients

A collaborative study published in the journal Brain Stimulation has shown that targeted electrical stimulation in epilepsy patients with traumatic brain injury (TBI) can...

Continued improvement of flow diverters and intrasacculars holds key to truly...

Laurent Pierot’s (Reims University Hospitals, Reims, France) long career in the treatment of intracranial aneurysms predates not only what many consider to be the...

Missing outcome data is common and ‘does not occur at random’...

The phenomenon of missing outcome data (MOD) within stroke registries of mechanical thrombectomy cases “is not a rare event and does not occur completely...

Massachusetts’ stroke triage updates will save lives and reduce disability, says...

Massachusetts patients experiencing stroke could soon have access to refined treatment, triage and transport protocols based on a provision in the US state’s new...

Nurami receives US FDA 510(k) clearance for resorbable dural repair graft

Nurami Medical, a medical device startup company, has received 510(k) clearance from the US Food and Drug Administration (FDA) for its electrospun nanofibre-based product, ArtiFascia...

Hubly cranial access drill compares favourably to established device in safety...

Hubly Surgical has announced the results from the first peer-reviewed study comparing the safety and efficacy of its recently US Food and Drug Administration...

Enspire announces publication of trial evaluating DBS plus rehab for stroke...

Enspire DBS Therapy has announced the publication of the results of the EDEN trial—an early feasibility study led by Cleveland Clinic (Cleveland, USA) researchers assessing...

US FDA grants de novo marketing request to BlueWind’s Revi system...

BlueWind Medical has announced that the US Food and Drug Administration (FDA) has granted a de novo marketing request for the Revi system—a “transformative”...

Kandu announces positive functional outcomes and low readmission rates in novel...

Kandu Health has announced preliminary outcomes from the first 40 stroke survivors served by its novel stroke recovery programme, which intends to support stroke...

US registry study reveals 75% of acute stroke patients wait more...

A new study led by researchers from the University of Chicago Medicine (Chicago, USA) has revealed that nearly 75% of acute stroke patients wait more than...

Hyperfine completes enrolment for pilot study assessing portable MRI in paediatric...

Hyperfine has announced completed enrolment for HOPE PMR—a multicentre, observational pilot study assessing portable magnetic resonance imaging (MRI) in children with neurological injury, using...

Flow announces pivotal trial results indicating tDCS headset is twice as...

Flow Neuroscience, the creator of the Flow transcranial direct current stimulation (tDCS) headset for at-home, non-invasive brain stimulation to treat depression, has announced the...

Imperative unveils new company structure intended to elevate stroke and vascular...

Imperative Care has announced a new organisational structure designed to accelerate the company’s growth across its businesses. As per an Imperative press release, this...

NeuroNews’ top 10 most popular stories of July 2023

NeuroNews’ 10 most popular stories from July reveal a huge amount of interest in the treatment of stroke patients with medium vessel occlusions (MeVOs)—with...

Health economic data show cost-dominance of Saluda’s EVOKE system over open-loop...

Saluda Medical has announced the publication of new health economic data in the Clinical Journal of Pain that provides “the strongest ever economic case” for the...

Report finds improved thrombectomy access at NHS hospitals using Brainomix’s AI...

More stroke patients are benefitting from life-changing treatment thanks to Brainomix's e-Stroke artificial intelligence (AI) platform, according to a recent report from the Oxford...

Systematic review and meta-analysis find stroke thrombectomy safe and effective in...

A study presented at last week’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August 2023, San Diego, USA) noted that mechanical thrombectomy—in...

‘Care hotel’ model can lower costs and shorten hospital stays after...

Using a ‘care hotel’ model, which discharges patients to a specialty hospital hotel after smaller surgeries, can lower costs and shorten patients’ time in...

Enspire announces US$17.6 million Series B financing to advance DBS plus...

Enspire DBS Therapy recently announced that it has raised US$17.6 million of committed capital in a Series B financing led by existing investor Cleveland Clinic Innovations....

Anuncia announces first successful implant of ReFlow mini flusher in hydrocephalus...

Anuncia Medical has announced the successful first implant of the company's US Food and Drug Administration (FDA)-cleared ReFlow mini flusher device. Performed on by neurosurgeon Samuel...

Imperative announces late-breaking data showing benefits of ‘angled-tip’ aspiration catheters

Imperative Care has announced late-breaking data from the Neurovascular Quality Initiative-Quality Outcome Database (NVQI-QOD) evaluating its Zoom stroke solution, which were presented at the...

Kernel unveils new Flow2 advancing neuroimaging system

Kernel has unveiled its Flow2 system, which the company claims will give researchers and clinicians “unprecedented access” to robust, functional magnetic resonance imaging (fMRI)-like...

Smartphone app reliably and autonomously recognises physical stroke signs in study

During a late-breaking abstract session at this year’s Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA), researchers discussed a...

New study finds surgical approaches safe and effective in ARUBA-eligible unruptured...

Contrary to the results of a seminal study in the field, a recent analysis presented at the Society of NeuroInterventional Surgery (SNIS) annual meeting...

Viz.ai announces study findings demonstrating real-world impact of AI-driven stroke technology

Viz.ai has announced the presentation of three new abstracts that demonstrate the real-world impact of the Viz neuro suite at this week’s Society of...

Less invasive ‘liquid biopsy’ holds potential to identify genetic mutations in...

A study presented yesterday at the Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) indicates that it may be...

EOSolutions announces 510(k) submission of Thinline 8Fr vascular access sheath

EOSolutions has announced the US Food and Drug Administration (FDA) 510(k) submission, through a design consulting firm, of the Thinline 8Fr sheath—a vascular access solution...

New data indicate clinical benefits of Imperative’s Zoom stroke solution in...

Imperative Care has announced multiple new pieces of data from studies evaluating its Zoom stroke solution, presented at the ongoing Society of NeuroInterventional Surgery...

Aidoc launches AI-powered Full Brain solution to “significantly expand” stroke detection

Aidoc has announced the launch of its “revolutionary” Full Brain solution, which the company claims will significantly expand the anatomy analysed by artificial intelligence...

Study indicates filter-tip stent retrievers may improve first-pass thrombectomy rates

Research presented at the ongoing Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has shown that different types of...

Microvention announces five-year WEB-IT data alongside two new device sizes

Microvention, a wholly owned subsidiary of Terumo Corporation, has announced the publication of five-year follow-up data from the WEB-IT trial and the addition of two...

New eligibility criteria including large-core strokes could boost thrombectomy rates “dramatically”

A study presented on the first day of the 2023 Society of NeuroInterventional Surgery (SNIS) annual meeting (31 July–4 August, San Diego, USA) has...

Neurovascular OBLs: Enhancing patient satisfaction and accessibility with advanced biplane systems

This advertorial, sponsored by Siemens Healthineers, is intended for US readers only. A neurosurgical clinic in Raleigh, USA recently opened an office-based lab (OBL)—specifically, the...

Early administration of antiplatelets may improve post-thrombectomy outcomes in stroke patients

Administering antiplatelet medication within 24 hours of a mechanical thrombectomy procedure may help stroke patients recover more successfully and prevent high-risk individuals from experiencing...

Route 92 announces publication of first-in-human study featuring FreeClimb 70 reperfusion...

Route 92 Medical has today announced the publication of a retrospective, first-in-human study featuring its FreeClimb 70 reperfusion system in the journal Interventional Neuroradiology....

Non-invasive VNS approach could enhance post-stroke recovery outcomes

A novel approach to vagus nerve stimulation (VNS) may enable successful post-stroke recovery without the need for “invasive and often-uninsured” traditional VNS therapies. A paper published...

Mainstay announces publication of three-year data from post-market follow up of...

Mainstay Medical recently announced the publication of three-year clinical data from the post-market clinical follow-up (PMCF) study of 33 ReActiv8 patients at five medical...

Anuncia announces US launch of second-generation ReFlow device to treat hydrocephalus

Anuncia Medical has announced the successful US commercial launch of the ReFlow mini flusher—a second-generation device for the treatment of hydrocephalus. According to a...

Elevating stroke care: Navigating the transition from primary to comprehensive centres

In a guest piece for NeuroNews, Thomas Devlin (Chattanooga, USA) and Michelle Luffey advise the community on how best to navigate the transition from...

Nicolab and Titan partner to improve prehospital workflows in acute stroke

Nicolab and Titan Neuroscience Research Australia have announced the formal signing of a Memorandum of Understanding (MOU) between the two organisations. The MOU outlines...

Hubly Surgical closes oversubscribed US$3 million seed funding round

Hubly Surgical has successfully closed its Series seed funding round at an oversubscribed US$3 million. As per a company announcement, this investment comes on the...

Nalu presents new study data on pain management with PNS and...

Nalu Medical, a company that has miniaturised neurostimulation implants for the management of chronic intractable pain for both peripheral nerve stimulation (PNS) and spinal...

Imperative gains US FDA clearance for Zoom 88 support and announces...

Imperative Care has announced US Food and Drug Administration (FDA) 510(k) clearance of its Zoom 88 large distal platform (LDP) support, a portfolio expansion...

Arsenal Medical announces treatment of first patient with NeoCast embolic biomaterial

Arsenal Medical has today announced enrolment of the first patient treated with the company’s investigational NeoCast embolic biomaterial for neurovascular conditions. The patient was successfully...

Recruitment in iVascular’s SEMTIC study passes halfway point

iVascular has announced that the SEMTIC study, evaluating the safety and efficacy of its comprehensive stroke thrombectomy treatment, is one step closer to providing...

“No significant difference” between aspiration and stent-retriever thrombectomy in medium vessel...

When utilised as a first-line technique for medium vessel occlusion (MeVO) stroke, aspiration and stent-retriever thrombectomy have demonstrated “no significant difference” in imaging-related or...

Insightec gains US FDA nod for five-year endpoint in MR-guided focused...

Insightec has announced US Food and Drug Administration (FDA) approval of the five-year study endpoint for what it claims is the largest prospective, long-term...

Magnus announces first treatments in OLO clinical trial of novel depression...

Magnus Medical has announced that the first participants have been treated in the Open Label Optimisation (OLO) clinical trial evaluating the effectiveness of the...

‘Intelligent suit’ supported by AI and electrical stimulation could enhance spinal...

Experts in Germany are working on an ‘intelligent suit’ with which they hope to significantly improve rehabilitation after a serious spinal cord injury. This...

Researchers develop geometric deep learning model with potential to more accurately...

Researchers in Germany have developed a new deep learning model for detecting stroke lesions, claiming that—by leveraging rich geometric information to segment brain stroke...

Interim analysis of MOOD trial produces positive neuromodulation data in depression...

Neurolief has announced positive results from a planned interim analysis of the ongoing, randomised controlled MOOD pivotal trial, which is studying Relivion DP—a novel...

Rapid Medical announces new data showing “significant advantages” of Comaneci for...

Rapid Medical has announced new clinical data demonstrating the “significant advantages” of its novel Comaneci embolisation assist device over established techniques to treat ruptured...

Flow-diverter performance “comparable” between PComAs and other supraclinoid aneurysms

The concluding findings of a systematic review and meta-analysis published in the journal Neurosurgery indicate that flow-diverter performance in posterior communicating artery (PComA) aneurysms...

Cognito presents MRI data showing efficacy of non-invasive gamma stimulation therapy...

Cognito Therapeutics has announced “robust, lobe-specific” changes in white matter volume and myelination in Alzheimer’s disease patients following six months of non-invasive gamma stimulation...

Education and collaboration key to continued advancement of painful diabetic neuropathy...

The neuromodulation space has proliferated significantly over the past few years, and one area in which this is most notable is with the expansion...

First US and French patients enrolled in Philips’ WE-TRUST study

Royal Philips has today announced enrolment of the first patients in both the USA and France into the large-scale WE-TRUST study—a multicentre, prospective randomised...

Research indicates women are less likely to be routed to comprehensive...

Despite having worse stroke symptoms and living within comparable distances to comprehensive stroke centres (CSCs), women with large vessel occlusion (LVO) acute ischaemic stroke...

Craniotomy and decompressive craniectomy achieve similar outcomes in acute subdural haematoma

The two prevailing techniques used during surgical treatments of traumatic acute subdural haematomas (SDHs)—craniotomy and decompressive craniectomy—have demonstrated broadly similar efficacy outcomes in a...

Evren Technologies launches Phoenix 100 system for vagus nerve stimulation research

Evren Technologies has announced the launch of its Phoenix 100 system, a “state-of-the-art” transcutaneous auricular vagus nerve stimulator (taVNS) research tool. The Phoenix 100 system is intended...

US centre achieves 87% drop in neurosurgical infection rates across two-year...

A US centre has achieved a steep drop in infection rates among its neurosurgery patients over a two-year period thanks to the implementation of...

Stryker announces commercial launch of Q guidance system with cranial guidance...

Stryker has commercially launched its Q guidance system with cranial guidance software to provide surgeons with an image-based planning and intraoperative guidance system that assists...

Flexible nanoelectrodes can “pave the way” for higher-resolution stimulation devices

Engineers at Rice University (Houston, USA) have created nanoelectrodes that are minimally invasive and exceptionally flexible—and, as such, have the potential to function as...

Hyperfine launches international study to assess Swoop system in stroke diagnosis...

Hyperfine, the company that created the Swoop system—which it claims is the world’s first US Food and Drug Administration (FDA)-cleared portable magnetic resonance (MR) brain imaging...

Is thrombectomy set to become the standard of care for medium...

With multiple large clinical trials currently underway to assess thrombectomy treatments in patients with medium vessel occlusion (MeVO) stroke, Johanna Ospel (Calgary, Canada) takes...

ZAP-X gyroscopic radiosurgery platform gains Chinese NMPA approval

ZAP Surgical Systems has announced that the company has received National Medical Products Administration (NMPA) approval in China for its ZAP-X gyroscopic radiosurgery platform. ZAP-X...

Zeta Surgical announces successful first treatment in neurosurgical navigation study

Zeta Surgical has successfully treated its first patient using the Zeta cranial navigation system as part of a first-in-human trial at the National Neuroscience Institute (NNI)...

Append Medical raises US$4.35 million in initial closing of extended series...

Append Medical has raised US$4.35 million as part of an extended series A round, which will be used to support the company's first-in-human trials of Appligator. Investors include...

“Definitive trial” needed to confirm desmopressin’s potential in ICH patients receiving...

The results of a clinical trial have shown that a drug commonly used for patients with bleeding disorders has the potential to lessen the...

Highly targeted brain stimulation achieves “very exciting” outcomes in acute ischaemic...

Highly targeted electrical stimulation to the brain has shown promise as a treatment option for acute ischaemic stroke, according to a pilot study led by University...

NeuroNews’ top 10 most popular stories of June 2023

In addition to a number of key study presentations from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), NeuroNews’ most popular stories...

MindRhythm announces first patient enrolment in pivotal study of novel stroke-detection...

MindRhythm, in partnership with Wayne State University School of Medicine (Detroit, USA), recently announced that the first patient has been enrolled in the pivotal...

Researchers uncover ‘mutant origin’ of intracranial aneurysms and report promising drug...

Researchers at the RIKEN Center for Brain Science (CBS) in Wako, Japan have discovered a set of related mutations that lead to intracranial aneurysms....

Nerivio neuromodulation therapy found to safely treat migraine in pregnant women

Theranica has announced the results of a study recently published in the journal Headache demonstrating the safety of its Nerivio device—a novel remote electrical...

LINNC 2023 examines neuroprotection, steerable microcatheters and other ‘next frontiers’

linnc 2023
Neuroprotective agents and steerable microcatheter technologies were among a number of potential new interventional neuroradiology (INR) frontiers showcased and discussed at this year’s LINNC...

First SynerFuse procedure performed by solo surgeon in two-level spinal fusion...

SynerFuse has announced that—for the first time in the world, it claims—a solo spine surgeon has performed the SynerFuse procedure in a two-level spinal...

New ENRICH-PLUS study set to build on recent positivity in haemorrhagic...

Just two months after announcing what it claims is the “world's first positive surgical trial” in haemorrhagic stroke, NICO Corporation is awarding a US$200,000...

Microvention announces commercial availability of ERIC retrieval device in the USA

Microvention, a wholly owned subsidiary of Terumo, has announced that the ERIC retrieval device is now commercially available in the USA for ischaemic stroke treatment, having...

Black patients nearly 50% less likely to receive revascularisation for PAD

A new study from Keck Medicine at the University of Southern California (USC; Los Angeles, USA) has uncovered “significant racial disparities” in the diagnosis, treatment and outcomes of...

InspireMD announces completed enrolment in C-Guardians US IDE trial

InspireMD today announced that it has completed enrolment of its ongoing C-Guardians US Investigational Device Exemption (IDE) clinical trial, designed to support potential US...

US and Chinese experts introduce new aneurysmal subarachnoid haemorrhage guidelines

Expert groups from the USA and China have separately introduced new guidelines relating to the management of aneurysmal subarachnoid haemorrhage (aSAH). The updated guidelines—spearheaded...

LivaNova announces randomisation of 150th bipolar depression patient in RECOVER clinical...

LivaNova has announced that the 150th bipolar depression patient has been randomised in its RECOVER clinical study—a prospective, multicentre, double-blinded randomised controlled trial investigating...

J Mocco

j mocco
As president of the Society of NeuroInterventional Surgery (SNIS), endovascular neurosurgeon J Mocco (Icahn School of Medicine at Mount Sinai, New York, USA) has...

AptaTargets announces publication of APRIL trial data in JAMA Neurology

As per a press release from AptaTargets, JAMA Neurology has published positive results from APRIL—a Phase 1b/2a clinical trial evaluating the safety and efficacy...

Cochrane Library urged to retract and revise recent SCS review over...

Pain physicians have urged the Cochrane Library to retract and revise a recent review of spinal cord stimulation (SCS) in the treatment of low...

Sensome and Asahi Intecc partner to further development of Clotild smart...

Sensome and Asahi Intecc have today announced a collaboration to develop the next-generation Clotild smart guidewire, with Asahi Intecc taking on the manufacturing role...

Incomplete imaging of transient ischaemic attack increases subsequent stroke risk

Transient ischaemic attacks (TIAs) encountered with incomplete neurovascular imaging in emergency departments (EDs) have been associated with higher odds of subsequent stroke within 90...

Kandu Health appoints new CEO and enrols first 50 patients in...

Imperative Care recently announced the appointment of Kirsten Carroll as the new CEO of Kandu Health—a digital health startup with the aim of improving quality...

Analysis shows substantial cost saving can be achieved with Philips’ DTAS...

Royal Philips has today announced the results of a health economics analysis published in the Journal of NeuroInterventional Surgery (JNIS) that show an “innovative approach” to the...

Vision recovery among potential benefits of endovascular therapy in PCA occlusion...

A multicentre study presented at the recent European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has found that vision recovery and an increased...

Combined neuroprotection therapy shows promise in experimental stroke model

A new study conducted by scientists at Louisiana State University (LSU) Health New Orleans Neuroscience Center of Excellence (New Orleans, USA) reports that the...

Researchers identify novel protein linked to ischaemic stroke risk in older...

By identifying plasma proteomic determinants of incident cardioembolic and non-cardioembolic ischaemic stroke, researchers in the USA have found a novel protein believed to be...

Imperative announces data demonstrating benefits of Zoom RDL system in neurointerventional...

Imperative Care has announced the publication of early clinical data in the Journal of NeuroInterventional Surgery (JNIS) from a single-centre evaluation of the Zoom RDL radial...

Precision Neuroscience begins first-in-human study of implantable BCI technology

Precision Neuroscience Corporation has announced that the first in-human procedures in a pilot clinical study of its neural implant system have been successfully completed....

Neuralace announces upcoming SEAT trial presentation among other clinical milestones

Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...

New study elucidates exact location of atherosclerotic plaque ruptures in carotid...

While the exact location of atherosclerotic plaque ruptures—a common cause of myocardial infarction (MI) and stroke—has previously been unknown, researchers at Lund University (Lund,...

NeuroNews’ top 10 most popular stories of May 2023

While a handful of our highlights from the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) unsurprisingly feature in NeuroNews’ most-read stories through...

MAGNA meta-analysis further supports clinical benefit of EVT in large-core infarct...

The MAGNA meta-analysis of individual patient data (IPD) has provided “strong, generalisable evidence” on the clinically meaningful benefits of endovascular therapy (EVT) in ischaemic...

Early Feasibility Study programme has potential to advance US neurovascular space

At a time when many of Europe’s medical technology markets are effectively going backwards due to complications created by the EU Medical Device Regulation...

Anuncia announces publication of “promising” hydrocephalus outcomes with ReFlow ventricular system

Anuncia Medical has announced that an article highlighting its US Food and Drug Administration (FDA)-cleared and CE-marked ReFlow ventricular system (Gen 1) with hydrocephalus...

Nalu Medical announces first enrolment in peripheral nerve stimulation RCT

Nalu Medical has announced the first patient enrolment in the COMFORT-2 randomised controlled trial (RCT), which will assess the company’s peripheral nerve stimulation (PNS)...

Combined thrombectomy technique fails to demonstrate superiority over aspiration alone

New data from the VECTOR randomised controlled trial—presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany)—have indicated that a mechanical thrombectomy...

NeuroNews issue 50 – US

Highlights: Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...

NeuroNews issue 50 – EU

Highlights: Positive results with the Woven EndoBridge (WEB; Microvention/Terumo Corporation) device—presented for the first time at the LINNC Americas Seminar (16–17 March, Miami, USA)—indicate...

TESLA trial misses primary endpoint but exhibits “strong suggestion” favouring endovascular...

The results of the TESLA trial were recently presented at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany), demonstrating a “strong suggestion”...

Penumbra expands computer-aided thrombectomy offering with Lightning Bolt 7 launch

Penumbra has announced the US Food and Drug Administration (FDA) clearance and launch of Lightning Bolt 7, which the company claims is the most...

Latest trial results prompt call to “elevate” intracranial haemorrhage management

Following the presentation of new trials assessing intracranial haemorrhage (ICH) treatment approaches, INTERACT3 and ENRICH, Craig Anderson (The George Institute for Global Health, Sydney,...

First surgical cases underway using Stryker’s Q guidance system with cranial...

Stryker has announced that Early Product Surveillance (EPS) cases utilising its Q guidance system with cranial guidance software are underway. The technology provides surgeons with...

IRIS data shed new light on how treatment delays may impact...

A collaboration analysing several major clinical trials has found that endovascular therapy (EVT) plus intravenous thrombolysis (IVT) is likely to be superior to EVT...

Nicolab awarded three-year contract to supply AI-powered stroke software in Australia

Nicolab has been awarded a prestigious three-year contract to supply stroke workflow software and advanced artificial intelligence (AI) diagnostics for the Victorian Stroke Telemedicine...

EOSolutions announces full commercial launch of Dr Banner balloon guide catheter

EOSolutions Corporation has announced the introduction of the Dr Banner balloon guide catheter (BGC), which boasts “unmatched features” for neurovascular procedures. As per a...

Performance feedback significantly reduces door-to-groin time in endovascular therapy

Supplying healthcare providers with performance feedback can significantly reduce the time between an ischaemic stroke patient arriving at a hospital and them subsequently receiving...

Brain-computer interface plus SCS therapy enables thought-controlled walking after spinal cord...

Onward Medical has announced a recent publication in Nature showing that a wireless brain-computer interface (BCI) can use patients’ thoughts to modulate ARC therapy....

“Sonolysis is back” after safely reducing endarterectomy stroke risk in randomised...

Positive results from a clinical trial involving a novel therapeutic procedure known as sonolysis—deployed during a carotid endarterectomy (CEA)—were presented at the recent European...

NeuroOne announces first clinical case using Evo sEEG electrode in robotic...

NeuroOne Medical Technologies has announced the first clinical case using the Evo stereoelectroencephalography (sEEG) electrode in robotic neurosurgery. Performed by William Bingaman at Cleveland Clinic in Cleveland,...

Pipeline Flex embolisation device deemed safe and effective in complex intracranial...

A retrospective study from China has concluded that the Pipeline Flex embolisation device (Medtronic) is safe and effective in the treatment of complex intracranial...

Artiria granted US FDA clearance for real-time, deflectable guidewire

Artiria Medical, a Swiss neurovascular company, has announced that its real-time, deflectable guidewire has been granted 510(k) clearance by the US Food and Drug...

Interim data find “no evidence of benefit” for carotid revascularisation additional...

Interim results from the ECST-2 randomised controlled trial (RCT) have shown no evidence that carotid stenosis patients with a low-to-intermediate stroke risk, treated with...

New data represent “fantastic news” in IVT despite lack of efficacy...

Results from the TIMELESS trial represent “fantastic news” on the safety of intravenous tenecteplase in selected late-window stroke patients, despite the drug failing to...

Structured ambulatory post-stroke care “requires further evaluation” following mixed trial results

While patients treated via a structured ambulatory post-stroke care programme (SANO) in a recent cluster-randomised study experienced better control of their cardiovascular risk factors...

STRIVE-2 neuroimaging standards provide “unique focus” on small vessel disease research

In an attempt to promote more consistent and higher quality research in the field of small vessel disease (SVD), international experts have published the...

Remote ischaemic conditioning fails to improve functional outcomes in acute stroke...

As per results from the RESIST study, remote ischaemic conditioning (RIC)—while not being associated with any major safety issues—has failed to improve functional outcomes...

Early anticoagulation after ischaemic stroke “reasonable” and “unlikely to cause harm”

An international clinical trial presented today at the European Stroke Organisation Conference (ESOC; 24–26 May, Munich, Germany) has demonstrated that—in people with ischaemic stroke...

AI tool outperforms human emergency call handlers in identifying stroke

A team of researchers from Denmark have developed a new artificial intelligence (AI) framework to address the number of strokes that go unrecognised by...

WEB 17 device maintains efficacy, safety across ruptured and unruptured aneurysms

The Woven EndoBridge (WEB) 17 device (Microvention/Terumo Corporation) has demonstrated positive efficacy and safety outcomes in the prospective, multicentre CLEVER study, indicating its utility...

RECOVER trial will provide “thorough understanding” of VNS response in depression...

A new randomised controlled trial (RCT)—the “largest ever” of its kind in the major depressive disorder (MDD) space—will attempt to provide a “thorough understanding”...

Open and endovascular surgery recommended over ligation in ruptured extracranial carotid...

Both open and endovascular surgical approaches are likely to produce improved outcomes compared to ligation in the treatment of ruptured extracranial carotid artery aneurysms....

ChatGPT outperforms medical students and matches residents on neurosurgical board-style questions

An analysis published in the Journal of Neurosurgery, which assessed ChatGPT’s (OpenAI) performance on a surrogate for neurosurgical board-style questions, has found that the...

Abbott gains US FDA nod to treat non-surgical back pain with...

Abbott has announced that the US Food and Drug Administration (FDA) has approved its spinal cord stimulation (SCS) devices for the treatment of chronic...

AHA: Systemic interventions key to tackling “enormous inequities” in stroke care

‘Upstream’ causes of health inequities related to stroke—such as structural racism and conditions of the places where people live, learn, work and play—have not...

RapidAI wins MedTech Breakthrough award for best new imaging solution

RapidAI announced recently that its combined haemorrhagic solution—Rapid ICH (intracranial haemorrhage) and Rapid Hyperdensity—has been selected as the “Best New Imaging Solution” in the...

Magnus shares study results indicating SAINT depression treatment changes abnormal brain...

Magnus Medical has shared promising results from a clinical trial published in the Proceedings of the National Academy of Sciences indicating that treatment with SAINT neuromodulation...

Office-based removal of sacral neuromodulation devices deemed safe and well-tolerated

As per a recently published retrospective chart review, the removal of sacral neuromodulation (SNM) devices in the office setting, under local anaesthesia, is a...

Carthera publishes “promising” results with SonoCloud-9 in glioblastoma patients

Carthera has announced the publication in The Lancet Oncology of results from a Phase 1 clinical trial carried out by scientists at Northwestern University...

MR CLEAN-LATE trial finds endovascular therapy safe and effective in late-presenting...

Endovascular therapy (EVT) has been deemed safe and effective in patients with ischaemic stroke caused by an anterior circulation large-vessel occlusion (LVO) who present...

Abbott announces expanded MRI labelling for Eterna spinal cord stimulation system

Abbott has announced that the US Food and Drug Administration (FDA) has approved expanded magnetic resonance imaging (MRI) labelling for its Eterna spinal cord...

European Academy of Neurology launches collaboration to address global brain disorder...

Earlier this week, the European Academy of Neurology (EAN) announced the launch of the Brain Health Mission, a collaborative initiative that aims to address...

‘We need better tools’—new intracranial stent devices required for rare stroke...

“Overall, we just need better tools” was one of the salient points delivered by Jane Khalife (Cooper University Health Care, Camden, USA) in a...

Hubly Surgical gains US FDA clearance for novel burr-hole placement device

Hubly Surgical has received 510(k) clearance from the US Food and Drug Administration (FDA) to market its Hubly Drill, which the company describes as an innovative...

Get Ahead of Stroke campaign launches Survive Stroke Week from 15–21...

The Get Ahead of Stroke campaign is launching Survive Stroke Week from 15–21 May—an observance aimed at increasing awareness of stroke symptoms and the...

World-renowned clot science drives outstanding EMBOTRAP stent retriever outcomes in MASTRO...

This advertorial is sponsored by CERENOVUS. The EMBOTRAP® family of revascularisation devices (CERENOVUS) is innovative within the stent retriever space due to its differentiated design...

Cerevasc to present data on minimally invasive CNS delivery system at...

Cerevasc has announced that data on its minimally invasive central nervous system (CNS) delivery system will be presented for the first time at the...

Computing the future: Exploring ChatGPT’s potential role in neurosurgical practice

Brian Fiani (Livonia, USA) and Ryan Jarrah (Rochester, USA) take a look at the neurosurgical implications of one of the hottest topics permeating not...

Systematic review queries how far PPTA aneurysm management is along “the...

A systematic review and analysis published in the journal Interventional Neuroradiology has examined how far along “the right path” management paradigms for persistent primitive trigeminal artery...

ConcertAI’s TeraRecon announces release of AI-driven Neuro Suite

ConcertAI's TeraRecon has announced the release of Neuro Suite, its artificial intelligence (AI)-driven clinical suite, which the company claims is purpose-built for disease triage,...

MIVI completes enrolment for study of Q revascularisation system in acute...

Q revascularisation system
MIVI Neuroscience has announced that it has completed enrolment in the EVAQ clinical trial to assess the safety and effectiveness of the Q revascularisation system...

Medical therapy improvements mean “the time has come” to reconduct prior...

“The time has definitely come to look at the evidence, and redo these studies,” posited Alun Davies (Imperial College London, London, UK), putting forward...

Clinical stroke research in Canada receives million-dollar grant boost

The Heart and Stroke Foundation, Brain Canada, and the Canadian Stroke Consortium, have announced the recipients of the 2022 Stroke Clinical Research Catalyst grants. The purpose of this...

NeuroNews’ top 10 most popular stories of April 2023

A number of potentially contentious issues caught the eye of our readers in April—including how best to define 'success' in stroke thrombectomy; efforts to...

NeuroOne announces US commercial launch of Evo sEEG electrodes

NeuroOne Medical Technologies has announced the commercial launch of the Evo stereoelectroencephalography (sEEG) electrode product line in the USA. Zimmer Biomet holds exclusive worldwide distribution rights...

Feinstein Institutes awarded US$3.4 million to study rTMS therapy in schizophrenia

Researchers at the Feinstein Institutes for Medical Research (Manhasset, USA) have received a US$3.4 million grant from Wellcome to study repetitive transcranial magnetic stimulation (rTMS) and its effects—potentially opening...

Stryker completes acquisition of Cerus Endovascular

Stryker announced today that it has completed the acquisition of Cerus Endovascular—a medical device company engaged in the design and development of neurointerventional devices...

Study finds worse post-stroke neurologic outcomes in Spanish-speaking Americans

New research has indicated that Mexican Americans have worse outcomes after a stroke than non-Hispanic white Americans. A recent study, which looked at whether the...

Cerenovus announces commercial availability of Cerepak detachable coils in USA

cerepak detachable coils
Cerenovus has announced that the new Cerepak detachable coils are now commercially available in the USA, and that the first patient cases have been...

Early diagnosis and treatment needed in “often underreported” post-stroke cognitive impairment

More than half of all stroke survivors may develop cognitive impairment within a year after their stroke, and one in three are at risk for developing dementia...

ESOC to return with fully on-site format and diverse stroke programme

Having taken place via a virtual format in 2021, and as a hybrid meeting last year, the 2023 European Stroke Organisation Conference (ESOC; 24–26...

SynerFuse announces presentation of IDE proof-of-concept study data

SynerFuse has announced that Michael Park (University of Minnesota, Minneapolis, USA)—principal investigator for the company’s investigational device exemption (IDE) proof-of-concept study—presented data from the study’s...

Vascular community split over “death” of traditional carotid stenting

A debate between two prominent carotid interventionists—Peter Schneider (University of California San Francisco, San Francisco, USA) and Domenico Valenti (King's College London, London, UK)—on...

Penumbra launches new RED 43 reperfusion catheter for mechanical thrombectomy

Penumbra recently announced the launch of the latest addition to its RED family of catheter devices for mechanical thrombectomy, the RED 43 reperfusion catheter. According...

NICO announces initial positive results from ENRICH trial

NICO Corporation has announced initial positive results from the completed ENRICH trial at the 2023 American Association of Neurological Surgeons (AANS) annual scientific meeting...

Route 92 gains US FDA clearance for complete stroke treatment system

Route 92 Medical has today announced receipt of 510(k) clearance from the US Food and Drug Administration (FDA) for its FreeClimb 70 reperfusion system,...

Biotronik announces US FDA approval of Prospera spinal cord stimulation system

Biotronik has announced US Food and Drug Administration (FDA) approval for Prospera—a new spinal cord stimulation (SCS) system. The system features RESONANCE, which the...

Cercare and ConcertAI partner to improve neurovascular clinical workflows

Cercare Medical has announced it will be bringing its neurovascular clinical workflows into ConcertAI's TeraRecon Eureka clinical artificial intelligence (AI) platform as part of...

ENRICH trial data on minimally invasive ICH surgery to be presented...

NICO Corporation has announced that the results from the completed ENRICH trial will be presented at the annual American Association of Neurological Surgeons (AANS)...

RapidAI receives US FDA 510(k) clearance for new imaging product to...

RapidAI announced today that it has received US Food and Drug Administration (FDA) 510(k) clearance for Rapid non-contrast computed tomography (NCCT) Stroke, which is...

New WIST guidelines seek to improve access and standardise training in...

A new set of guidelines intended to standardise and expand stroke thrombectomy training have been published simultaneously in Europe, in the journal Advances in...

Nerivio demonstrates real-world effectiveness as migraine treatment in adolescents

Theranica recently had the results from a real-world analysis of Nerivio for acute treatment of migraine in adolescents published in the journal Pediatric Neurology....

Michael J Fox Foundation announces “significant breakthrough” in search for Parkinson’s...

A “landmark” paper published in The Lancet Neurology by leaders of the Parkinson's Progression Markers Initiative (PPMI)—a study sponsored by The Michael J Fox Foundation (MJFF)...

The new standard for SCS therapy—neural activation measurement, targeting and maintenance

Jason Pope (Santa Rosa, USA) discusses closed-loop spinal cord stimulation (SCS) and its potential to provide sustained, holistic outcomes for chronic pain patients. In...

Initial cases indicate lithotripsy can help TCAR expand into high-risk patients

Lithotripsy may hold the key to enabling more carotid artery disease patients who require calcification treatment to undergo stent placement via a transcarotid artery...

Adept launches Adducted Arm Scoop product for use during image-guided procedures

Adept Medical has launched the Adducted Arm Scoop—an improved solution for supporting the adducted arms of supine patients during image-guided procedures. Adept’s new, “extremely durable”...

Saluda, Neuromod, Neuvotion secure funding rounds to boost neuromodulation technologies

This week, three companies developing novel neuromodulation technologies for use in the treatment of various neurological disorders have each separately announced the receipt of...

Evidence indicates effectiveness of brain stimulation in upper-limb stroke rehabilitation

Moderate- to high-quality evidence suggests that specific neuromodulation modalities can provide effective treatments in patients undergoing stroke rehabilitation. As per a systematic review and...

Annalise.ai gains seven new 510(k) clearances for brain and chest imaging...

Annalise.ai has received US Food and Drug Administration (FDA) 510(k) clearances covering an additional seven findings as part of the company's innovative artificial intelligence...

DAPT at discharge reduces stroke and mortality risk versus other drug...

A recent data presentation has revealed reduced risk of stroke and mortality among transcarotid artery revascularisation (TCAR) patients who receive dual antiplatelet therapy (DAPT),...

Reach Neuro receives Breakthrough Device designation for restorative stimulation device in...

Reach Neuro has been granted a Breakthrough Device designation by the US Food and Drug Administration (FDA) for its Avantis platform, which uses small...

Tenecteplase linked to higher haemorrhage rates than alteplase in no-thrombectomy stroke...

Intravenous tenecteplase was associated with a higher rate of intracranial haemorrhage (ICH), as compared to alteplase, in a recent analysis of real-world data from...

New study shows benefits of BioWave’s peripheral nerve stimulation in chronic...

The peer-reviewed journal Pain and Therapy recently published a new study, titled "Reduced pain and improved function following short-term use of non-invasive BioWave high-frequency peripheral...

First-pass effect or rule of three? Definition of procedural success remains...

While a number of companies in the neurovascular space have become increasingly focused on the ‘first-pass effect’ in mechanical thrombectomy treatments, many major clinical...

Intraoperative adverse events found to impede favourable outcomes in microsurgical aneurysm...

A nationwide study drawing on data from Swedish patients has indicated that—while the majority of ruptured intracranial aneurysm patients treated with microsurgery experienced favourable...

New spectroscopy probe could enhance deep brain stimulation procedures for Parkinson’s

A new probe that performs two types of spectroscopy could make deep brain stimulation (DBS) procedures safer and improve success rates by helping doctors...

Paediatric case helps highlight benefit of ‘aspiration first’ in young stroke...

A unique case presentation at this year’s LINNC Americas Seminar (16–17 March, Miami, USA) saw Rafael de Oliveira Sillero (University of Texas Southwestern Medical...

Astrocyte to initiate extended infusion Phase 1b study of cerebroprotective drug

Astrocyte Pharmaceuticals has announced the initiation of a Phase 1b study of its lead cerebroprotective candidate, AST-004, as an extended infusion in healthy volunteers....

CHI Memorial announces participation in “milestone” stroke study with novel ultrasound...

The Catholic Health Initiatives (CHI) Memorial Stroke and Neuroscience Center has announced its participation in the national research study, BUBL, stating that it was...

Stent-assisted coiling fails to show superiority versus coiling alone in unruptured...

stat trial coiling
A randomised controlled trial (RCT) involving more than 200 patients has indicated that stent-assisted coiling (SAC) is not superior to coiling alone in unruptured...

NeuroNews’ top 10 most popular stories of March 2023

In addition to the US approval of a unique neurovascular device, discussions around female physicians in the neurointerventional space; pushback against the European Union’s...

Review concludes SCS benefits do not outweigh associated risks and costs...

A recently published Cochrane review has concluded that the clinical benefits of spinal cord stimulation (SCS) do not outweigh the risks and costs associated...

NeuroNews issue 49 – US

Highlights: The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...

NeuroNews issue 49 – EU

Highlights: The 2023 International Stroke Conference (ISC; 8–10 February, Dallas, USA) is punctuated by new data on neuroprotective medications in ischaemic stroke, sparking tempered...

Trial underway involving neurointerventionist “retaliated against” for refusing concurrent on-call shifts

The opening statements and presentation of evidence are set for 10am PST today in a lawsuit involving claims that a medical doctor and his...

Chest, Heart and Stroke Scotland applauds decision to reinstate “vital” thrombectomy...

The charity Chest, Heart and Stroke Scotland (CHSS) has voiced support for the Scottish government’s decision to reinstate “vital” funding of thrombectomy services across...

Dual antiplatelet therapy linked to better post-TCAR outcomes versus other drug...

Dual antiplatelet therapy (DAPT) has demonstrated improved clinical outcomes, including reduced in-hospital stroke and mortality risks, compared to other medication regimens in carotid artery...

Q’Apel Medical granted CE-mark approval for Walrus balloon guide catheter

Q'Apel Medical has been granted a CE mark under the European Medical Device Regulation (MDR) for Walrus, its balloon guide catheter (BGC) product used...

Vitor Mendes Pereira

vitor mendes pereira
As medical accolades go, performing the world’s first robot-assisted neurointerventional procedure—a feat that Vitor Mendes Pereira and his team achieved back in 2019—is something...